Malignant neoplasm of eye, brain and central nervous system

C3_EYE_BRAIN_NEURO

brain neoplasm: A neoplasm (disease) that involves the brain.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints C3_EYE_ADNEXA C3_MENINGES C3_BRAIN C3_SPINAL_CORD_CRANIAL_AND_OTHER_CNS	2026
6. Filter based on genotype QC (FinnGen only)	1807

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4

NAME	C3_EYE_BRAIN_NEURO
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_EYE_ADNEXA\|C3_MENINGES\|C3_BRAIN\|C3_SPINAL_CORD_CRANIAL_AND_OTHER_CNS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of eye, brain and central nervous system based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1807	798	1009
Unadjusted period prevalence (%)	0.38	0.28	0.46
Median age at first event (years)	59.87	57.37	61.85

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1877: Matched controls
18770

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

158.9

322.7

160

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

602.7

316.1

305

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

448.2

311.9

304

A03FA01

ATC

metoclopramide; systemic, rectal

15.4

307.7

967

1215

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

307.7

339

L01AX03

ATC

temozolomide; systemic

+∞

307.7

834

Z51.5

ICD-10 Finland

Palliative care

28.9

307.7

608

306

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

1046

A04AA01

ATC

ondansetron; systemic, rectal

30.0

307.7

484

215

ZXC95

NOMESCO Finland

Use of surgical navigator

65.4

307.7

365

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

31.6

307.7

493

209

N03AX14

ATC

levetiracetam; systemic

61.1

307.7

722

190

WF003

NOMESCO Finland

Adjuvant radiotherapy

+∞

307.7

385

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

597.5

307.7

487

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

30.6

307.7

341

135

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

29.0

307.7

997

706

N03AX18

ATC

lacosamide; systemic

65.2

307.7

209

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

800.2

307.7

909

WF002

NOMESCO Finland

Radical radiotherapy

728.8

307.7

562

A04AA02

ATC

granisetron; systemic, transdermal

1097.9

307.7

601

H02AB02

ATC

dexamethasone; systemic

356.2

307.7

1214

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

55.7

307.7

554

140

XX3DW

NOMESCO Finland

Time consuming IT work

18.9

307.7

515

369

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

26.5

307.7

760

470

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

27.5

307.7

337

148

N03AF02

ATC

oxcarbazepine; oral

13.3

305.4

310

275

ZXC40

NOMESCO Finland

Use of ultrasound

83.2

301.3

160

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

3119.1

296.8

279

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

159.4

296.5

147

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

292.6

273

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

1057.5

285.0

272

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

+∞

272.7

255

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

+∞

268.3

251

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

+∞

267.2

250

AA1AD

NOMESCO Finland

CT of head and brain

5.0

265.1

1025

3630

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

949.7

258.7

248

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

+∞

249.7

234

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

+∞

247.5

232

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

+∞

233.3

219

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

+∞

230.0

216

R56.8

ICD-10 Finland

Other and unspecified convulsions

8.0

213.8

321

473

AA1BD

NOMESCO Finland

Extensive CT of head and brain

17.4

208.0

175

110

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

27.4

203.3

140

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

15.2

198.6

180

130

N02AA05

ATC

oxycodone; systemic

5.0

198.1

545

1427

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

681.2

190.4

185

JN4BD

NOMESCO Finland

Extensive body CT

8.5

186.4

259

347

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

28.4

184.1

125

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

27.2

184.1

127

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

491.2

182.4

179

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

12.9

181.0

181

154

WX882

NOMESCO Finland

High dependency care

10.2

180.5

214

234

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

180.2

170

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.3

175.1

417

960

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

4.4

173.8

574

1716

9440/3-C71.9

ICD-O-3

Glioblastoma, NOS, of brain, NOS

+∞

173.7

164

G40.9

ICD-10 Finland

Epilepsy, unspecified

8.7

172.4

234

304

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

457.7

170.6

168

C71.12

ICD-10 Finland

Malignant tumor of frontal lobe grade III glioma

+∞

170.5

161

XA800

NOMESCO Finland

Neuropsychological investigation

7.4

170.2

268

413

G40.10

ICD-10 Finland

Simple partial seizures

38.5

165.1

102

WZC00

NOMESCO Finland

Treatment plan or consultation

3.6

160.1

871

3633

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

159.7

151

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

159.7

151

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

26.2

156.3

109

9440/3-C71.2

ICD-O-3

Glioblastoma, NOS, of temporal lobe

+∞

152.2

144

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

147.9

140

WF004

NOMESCO Finland

Palliative radiotherapy

+∞

140.4

133

ZX050

NOMESCO Finland

Stereotactic radiotherapy

303.6

139.4

140

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1445.5

139.4

134

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

+∞

137.2

130

XCD10

NOMESCO Finland

Electrophysiological examination of eye

10.4

137.2

158

165

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

29.8

136.7

ZXE20

NOMESCO Finland

More than three and less than five hours

4.4

136.7

414

1142

C69.32

ICD-10 Finland

Malignant tumor of the chorioidea melanoma

+∞

136.1

129

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

477.9

136.0

134

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

+∞

131.8

125

N05CD08

ATC

midazolam; nasal, systemic

9.7

129.5

156

173

C71.21

ICD-10 Finland

Malignant tumor of temporal lobe grade II glioma

+∞

128.6

122

JN4AD

NOMESCO Finland

Body CT examination

5.7

126.7

257

506

N05BA09

ATC

clobazam; oral

26.0

124.7

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

6.0

123.1

234

433

N03AB02

ATC

phenytoin; systemic

15.1

122.8

110

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

20.8

121.7

C71.33

ICD-10 Finland

Malignant tumor of parietal lobe grade IV glioma

+∞

121.2

115

ZX090

NOMESCO Finland

Other technic of radiotherapy

256.2

118.3

120

C71.3

ICD-10 Finland

Malignant neoplasm: Parietal lobe

+∞

118.0

112

ZX070

NOMESCO Finland

Intensity modified radiotherapy

610.0

117.4

115

9440/3-C71.1

ICD-O-3

Glioblastoma, NOS, of frontal lobe

+∞

116.9

111

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

251.6

116.2

118

N74

ICPC

Malignant neoplasm nervous system

598.7

115.3

113

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

112.6

107

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

238.0

109.9

112

WZC30

NOMESCO Finland

Teaching

3.8

109.3

409

1297

WX402

NOMESCO Finland

General anaesthesia

3.2

107.3

555

2156

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

14.8

107.2

C71.22

ICD-10 Finland

Malignant tumor of temporal lobe grade III glioma

+∞

106.3

101

C71.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of brain

+∞

104.1

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

+∞

102.0

WX408

NOMESCO Finland

General anesthesy, balanced

3.0

99.2

598

2522

H02AB09

ATC

hydrocortisone; systemic

9.0

95.8

121

142

AAA10

NOMESCO Finland

Biopsy through craniotomy

965.5

94.8

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

204.4

94.3

L03AA02

ATC

filgrastim; parenteral

147.6

93.0

WW500

NOMESCO Finland

Blood transfusion

9.2

90.5

112

128

C69.3

ICD-10 Finland

Malignant neoplasm: Choroid

+∞

89.3

H53.4

ICD-10 Finland

Visual field defects

8.3

88.8

120

153

A02BC02

ATC

pantoprazole; systemic

2.9

87.9

1419

9663

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

14.7

87.3

C71.19

ICD-10 Finland

Malignant tumor of frontal lobe other or unspecified histology

+∞

87.2

C71.83

ICD-10 Finland

Overall malignant tumor of the brain grade IV glioma

+∞

86.1

C71.29

ICD-10 Finland

Malignant tumor in temporal lobe other or unspecified histology

+∞

86.1

8000/3-C71.9

ICD-O-3

Neoplasm, malignant of brain, NOS

+∞

85.0

8720/3-C69.3

ICD-O-3

Malignant melanoma, NOS, of choroid

+∞

84.0

C71.00

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles without histology

+∞

84.0

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

82.9

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.0

82.0

452

1790

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

9.4

82.0

100

112

L03AA13

ATC

pegfilgrastim; parenteral

420.3

81.6

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

18.7

81.4

C71.9

ICD-10 Finland

Malignant neoplasm: Brain, unspecified

+∞

80.8

A79

ICPC

Malignancy NOS

414.8

80.5

ZXE30

NOMESCO Finland

More than five and less than seven hours

5.7

78.9

153

286

C61

ICD-10 Finland

Malignant neoplasm of prostate

403.9

78.4

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

77.6

WF049

NOMESCO Finland

Radiotherapy of metastasis

398.4

77.4

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

40.1

76.9

D70.82

ICD-10 Finland

Drug-induced neutropenia

30.2

75.5

JN4CD

NOMESCO Finland

Very extensive body CT

11.0

73.8

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

197.9

73.7

8720/3-C69.9

ICD-O-3

Malignant melanoma, NOS, of eye, NOS

+∞

72.4

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

7.9

71.7

101

135

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

71.3

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

70.2

ZXM40

NOMESCO Finland

Use of fluorescent substance

187.1

69.6

XW000

NOMESCO Finland

Bone marrow biopsy

7.4

69.5

103

146

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

69.2

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

25.9

68.8

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

10.1

68.1

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

+∞

68.1

ZXD10

NOMESCO Finland

Scheduled procedure

2.3

67.2

786

4418

9440/3-C71.3

ICD-O-3

Glioblastoma, NOS, of parietal lobe

+∞

67.1

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

660.5

65.3

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

+∞

65.0

R4150

NOMESCO Finland

Neuropsychological rehabilitation

13.7

65.0

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

63.9

9400/3-C71.1

ICD-O-3

Astrocytoma, NOS, of frontal lobe

+∞

63.9

WX140

NOMESCO Finland

Parabulbar anesthesy

4.5

63.6

166

399

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

16.3

63.4

C71.80

ICD-10 Finland

Overall malignant tumor of the brain without histology

+∞

62.9

WX872

NOMESCO Finland

Intensive care

4.1

62.0

182

478

R4110

NOMESCO Finland

Physiotherapy

2.4

59.9

586

3021

9450/3-C71.1

ICD-O-3

Oligodendroglioma, NOS, of frontal lobe

+∞

59.7

CFA20

NOMESCO Finland

Biopsy of conjunctiva

27.2

58.3

N76

ICPC

Neoplasm nervous system unspecified

128.2

58.2

R4120

NOMESCO Finland

Occupational therapy

3.7

58.1

202

597

ZXE10

NOMESCO Finland

More than one and less than three hours

2.2

57.7

714

4050

115

Kela drug reimbursment

Breast cancer

+∞

57.6

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

57.6

C71.31

ICD-10 Finland

Malignant tumor of the parietal lobe grand II glioma

+∞

56.5

183

Kela drug reimbursment

Lamotrigin and topiramate

11.0

55.9

9400/3-C71.9

ICD-O-3

Astrocytoma, NOS, of brain, NOS

+∞

55.5

XX2RW, ,

NOMESCO Finland

14.1

55.5

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

16.2

53.9

JN6AD

NOMESCO Finland

CT of torso and neck

15.5

53.8

N03AG01

ATC

valproic acid; systemic, rectal

3.5

52.6

196

605

N03AF01

ATC

carbamazepine; oral, rectal

3.9

51.6

164

455

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

267.8

51.4

C71.32

ICD-10 Finland

Malignant tumor of parietal lobe grade III glioma

+∞

51.3

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

49.9

433

2096

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

500.7

49.6

PJA12

NOMESCO Finland

Sentinel node biopsy

+∞

49.2

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

8.5

49.0

B01AB10

ATC

tinzaparin; parenteral

3.2

48.6

215

737

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

48.1

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

8.4

48.1

R90.0

ICD-10 Finland

Intracranial space-occupying lesion

90.9

48.1

A28

ICPC

Limited function/disability NOS

2.4

47.3

413

2000

C71.93

ICD-10 Finland

Malignant tumor in an unspecified localization in the brain grade IV glioma

+∞

47.1

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

128.4

47.0

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

15.5

46.9

N05CF01

ATC

zopiclone; oral

2.1

46.8

662

3887

A04AA55

ATC

palonosetron, combinations; systemic

+∞

46.0

C71.40

ICD-10 Finland

Malignant tumor of the occipital lobe without histology

+∞

46.0

G91.1

ICD-10 Finland

Obstructive hydrocephalus

15.3

44.3

C71.43

ICD-10 Finland

Malignant tumor of the occipital lobe grade IV glioma

+∞

43.9

C71.01

ICD-10 Finland

Malignant tumor of cerebellum except lobes and ventricles grade II glioma

+∞

43.9

WX002

NOMESCO Finland

Sedation and analgesia

2.3

43.4

400

1974

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

42.9

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

41.8

G41.9

ICD-10 Finland

Status epilepticus, unspecified

13.2

41.8

TAB00

NOMESCO Finland

Lumbar puncture

3.8

41.2

133

372

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

41.1

443

2326

C69.39

ICD-10 Finland

Malignant tumor in chorioidea other or unspecified histology

+∞

40.8

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

7.3

40.4

G40.89

ICD-10 Finland

Other epilepsy

14.0

40.0

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

39.7

Z51.0

ICD-10 Finland

Radiotherapy session

395.5

39.2

ZXA05

NOMESCO Finland

Left side

2.1

38.8

473

2597

C71.39

ICD-10 Finland

Malignant tumor of parietal lobe other or unspecified histology

+∞

38.7

116

Kela drug reimbursment

Prostate cancer

+∞

38.7

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

38.7

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.0

38.5

119

WW300

NOMESCO Finland

Transfer of autologic stem cells

385.0

38.2

HAB40

NOMESCO Finland

Wedge excision of mammary gland

15.3

37.4

WX110

NOMESCO Finland

Infiltration anesthesia

2.0

37.0

1333

10437

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

36.9

197

747

C71.4

ICD-10 Finland

Malignant neoplasm: Occipital lobe

+∞

36.6

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

364.1

36.1

ABB10

NOMESCO Finland

Resection of lesion of spinal canal

129.2

35.8

TPH07

NOMESCO Finland

Cathetrisation of artery

2.6

35.8

231

965

ZXA00

NOMESCO Finland

Right side

2.0

35.7

507

2930

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

35.6

366

1876

L02AE02

ATC

leuprorelin; implant, parenteral

10.8

34.9

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

33.9

870

6060

XCK10

NOMESCO Finland

Photography of fundus of eye

2.5

33.6

225

955

9450/3-C71.9

ICD-O-3

Oligodendroglioma, NOS, of brain, NOS

+∞

33.4

WX704

NOMESCO Finland

Intubation

2.8

33.3

180

686

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

9.3

33.1

Z2445

NOMESCO Finland

Psychologist

3.5

33.0

117

348

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

7.0

32.7

Z2446

NOMESCO Finland

Social worker

2.9

32.5

162

591

9391/3-C72.0

ICD-O-3

Ependymoma, NOS, of spinal cord

+∞

32.4

B01AB05

ATC

enoxaparin; parenteral

1.9

31.9

515

3091

C71

ICD-10 Finland

Malignant neoplasm of brain

+∞

31.3

C71.0

ICD-10 Finland

Malignant neoplasm: Cerebrum, except lobes and ventricles

+∞

31.3

A98

ICPC

Health maint/preventive medicine

0.5

30.5

1481

16568

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

30.3

9400/3-C71.2

ICD-O-3

Astrocytoma, NOS, of temporal lobe

+∞

30.3

C71.89

ICD-10 Finland

Overall malignant tumor of the brain other or unspecified histology

+∞

30.3

C69.02

ICD-10 Finland

Malignant tumor in conjunctival melanoma

+∞

30.3

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

307.2

29.9

HAC20

NOMESCO Finland

Total mastectomy

157.5

29.7

8000/3-C69.3

ICD-O-3

Neoplasm, malignant of choroid

+∞

29.2

9510/3-C69.2

ICD-O-3

Retinoblastoma, NOS, of retina

+∞

29.2

C69.00

ICD-10 Finland

Malignant tumor of the conjunctiva without histology

+∞

29.2

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

29.2

R47.0

ICD-10 Finland

Dysphasia and aphasia

6.5

29.1

N03AX23

ATC

brivaracetam; systemic

32.3

29.1

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

6.6

29.1

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.8

28.6

157

603

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

49.4

28.5

C71.03

ICD-10 Finland

Malignant tumor of cerebellum except lobes and ventricles grade IV glioma

+∞

28.2

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

28.2

9401/3-C71.1

ICD-O-3

Astrocytoma, anaplastic, NOS, of frontal lobe

+∞

28.2

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

43.2

27.8

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.5

27.4

288

R4130

NOMESCO Finland

Speech therapy

4.0

27.3

209

C71.82

ICD-10 Finland

Overall malignant tumor of the brain grade III glioma

+∞

27.1

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

27.1

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

24.2

27.0

AA5FG

NOMESCO Finland

Functional MRI examination of brain with high intensity magnet

274.9

26.8

Z3229

NOMESCO Finland

Other healthcare associate professional

2.5

26.8

189

820

CAA30

NOMESCO Finland

Biopsy of orbit

142.1

26.7

Z3231

NOMESCO Finland

Registered nurse

1.8

26.3

487

3027

N05BA04

ATC

oxazepam; oral

1.8

26.1

497

3113

ZX120

NOMESCO Finland

Intravenous

2.7

26.0

153

608

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.3

25.9

213

989

G40

ICD-10 Finland

Epilepsy

6.4

25.8

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.3

25.7

160

WW200, ,

SPAT

0.5

25.7

203

3977

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.0

25.4

117

408

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

50.8

25.3

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

25.1

C72.00

ICD-10 Finland

Malignant tumor of the spinal cord without histology

+∞

25.1

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

253.4

24.7

HA1AA

NOMESCO Finland

X-ray mammography

3.8

24.5

211

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.5

24.2

134

C71.81

ICD-10 Finland

Overall malignant tumor of the brain grade II glioma

+∞

24.0

9440/3-C71.0

ICD-O-3

Glioblastoma, NOS, of cerebrum

+∞

24.0

D69.5

ICD-10 Finland

Secondary thrombocytopenia

68.3

23.9

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

68.3

23.9

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.8

23.8

ABB00

NOMESCO Finland

Excision of lesion of spinal canal

31.5

23.7

C71.70

ICD-10 Finland

Malignant tumor of the brainstem without histology

+∞

23.0

9451/3-C71.1

ICD-O-3

Oligodendroglioma, anaplastic, NOS, of frontal lobe

+∞

23.0

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

+∞

23.0

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.8

22.4

120

454

CF2S4

NOMESCO Finland

Photography of conjunctiva

52.7

22.1

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

8.6

21.9

9382/3-C71.1

ICD-O-3

Oligoastrocytoma, NOS, of frontal lobe

+∞

21.9

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

21.9

C71.91

ICD-10 Finland

Malignant tumor in unspecified location in the brain grade II glioma

+∞

21.9

1906B

ICD-9 Finland

Malignant neoplasm of eye, Choroid[MELANOMA CHORIOIDEAE]

+∞

21.9

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

21.9

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

21.9

ZX112

NOMESCO Finland

Subcutaneous

7.0

21.7

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

222.5

21.6

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

5.6

21.5

N03AX22

ATC

perampanel; oral

31.6

21.5

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.5

21.5

201

3747

WZC15, ,

NOMESCO Finland

43.9

21.4

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.6

21.3

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

21.1

351

2095

WX730

NOMESCO Finland

Conventional respirator

5.0

20.9

9440/3-C71.8

ICD-O-3

Glioblastoma, NOS, of overlapping lesion of brain

+∞

20.9

C71.7

ICD-10 Finland

Malignant neoplasm: Brain stem

+∞

20.9

XX1AD

NOMESCO Finland

Other CT-examination

77.7

20.7

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

3.7

20.7

188

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

20.6

196

963

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

20.4

178

844

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

4.7

20.1

103

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.1

19.9

211

1080

C69.21

ICD-10 Finland

Retina

+∞

19.8

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

19.8

C71.65

ICD-10 Finland

Malignant tumor of the cerebellum primary neuroectodermal tumor

+∞

19.8

C71.60

ICD-10 Finland

Malignant tumor of cerebellum without histology

+∞

19.8

C50.99

ICD-10 Finland

Breast, unspecified

+∞

19.8

N18

ICPC

Paralysis/weakness

3.6

19.8

189

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

40.5

19.5

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

19.3

297

1726

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

31.6

19.3

H02AB04

ATC

methylprednisolone; systemic

1.9

19.3

268

1508

XA400

NOMESCO Finland

EEG

8.0

19.2

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

18.8

9440/3-C71.4

ICD-O-3

Glioblastoma, NOS, of occipital lobe

+∞

18.8

C69.03

ICD-10 Finland

Malignant tumor of conjunctival carcinoma

+∞

18.8

C71.50

ICD-10 Finland

Malignant tumor of cerebral ventricle without histology

+∞

18.8

C72.09

ICD-10 Finland

Malignant tumor of the spinal cord other histology

+∞

18.8

L02BB03

ATC

bicalutamide; oral

+∞

18.8

180

Kela drug reimbursment

Interferon alfa

+∞

18.8

C72.01

ICD-10 Finland

Malignant tumor of the spinal cord grade II glioma

+∞

18.8

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

18.8

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

18.8

C71.02

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles grade III glioma

+∞

18.8

9401/3-C71.2

ICD-O-3

Astrocytoma, anaplastic, NOS, of temporal lobe

+∞

18.8

G93.6

ICD-10 Finland

Cerebral oedema

+∞

18.8

WPB10

NOMESCO Finland

Making a convalescent care decision

38.8

18.6

WW409

NOMESCO Finland

Other aferesis

191.8

18.6

C82.1

ICD-10 Finland

Follicular lymphoma grade II

191.8

18.6

WX725

NOMESCO Finland

Noninvasive ventilation

2.6

18.5

113

457

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.8

18.4

330

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

30.4

18.3

N05BA06

ATC

lorazepam; systemic, sublingual

2.6

18.3

110

442

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.9

18.3

315

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

25.3

18.2

A06AD11

ATC

lactulose; oral

1.9

18.1

268

1536

Z2221

NOMESCO Finland

Medical doctor

1.7

18.1

450

2992

101

Kela drug reimbursment

Anterior pituitary hypofunction

6.2

18.1

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

5.0

18.1

CFC00

NOMESCO Finland

Excision of lesion of conjunctiva

15.5

18.0

C10AX09

ATC

ezetimibe; oral

0.4

17.8

2148

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

17.8

204

1073

C71.09

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology

+∞

17.7

L01BC06

ATC

capecitabine; oral

+∞

17.7

C71.6

ICD-10 Finland

Malignant neoplasm: Cerebellum

+∞

17.7

XX7GT

NOMESCO Finland

Selective internal radio therapy (SIRT) with Yttrium

+∞

17.7

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

+∞

17.7

9401/3-C71.9

ICD-O-3

Astrocytoma, anaplastic, NOS, of brain, NOS

+∞

17.7

C69.40

ICD-10 Finland

Malignant tumor of ciliary body without histology

+∞

17.7

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

17.7

C10AA07

ATC

rosuvastatin; oral

0.6

17.6

281

4485

Y77

ICPC

Malignant neoplasm prostate

181.6

17.5

A04AD12

ATC

aprepitant; systemic

181.6

17.5

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

5.6

17.5

WX892

NOMESCO Finland

Monitored bed care

2.2

17.4

151

714

R50.9

ICD-10 Finland

Fever, unspecified

1.9

17.4

264

1525

ZXH01

NOMESCO Finland

Procedure performed within operation theatre

42.4

17.3

D31.0

ICD-10 Finland

Benign neoplasm: Conjunctiva

6.4

17.1

Z02.4

ICD-10 Finland

Examination for driving licence

0.5

17.0

222

3764

ZXD05

NOMESCO Finland

Urgent procedure

1.6

16.9

512

3569

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

14.2

16.8

C69.42

ICD-10 Finland

Malignant tumor of ciliary melanoma

+∞

16.7

9699/3-C69.0

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of conjunctiva

+∞

16.7

C70.0

ICD-10 Finland

Malignant neoplasm: Cerebral meninges

+∞

16.7

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

+∞

16.7

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

7.0

16.6

2151

FHL

Resection, big brain

171.5

16.5

CDC10

NOMESCO Finland

Enucleation of eye with insertion of prosthesis

171.5

16.5

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

20.2

16.4

R93.0

ICD-10 Finland

Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified

20.2

16.4

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

5.4

16.4

PA2AD

NOMESCO Finland

CT angiography of brain

5.7

16.3

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

3.9

16.3

126

L02BG04

ATC

letrozole; oral

4.5

15.9

RS221, ,

NOMESCO Finland

4.5

15.7

C71.59

ICD-10 Finland

Malignant tumor of cerebral ventricle other or unspecified histology

+∞

15.6

3770

FHL

Placing a radiating plate on the surface of the eye with additional measures

+∞

15.6

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

15.6

OAA41

NOMESCO Finland

Health check based on individual needs

+∞

15.6

9699/3-C69.6

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of orbit, NOS

+∞

15.6

G41.2

ICD-10 Finland

Complex partial status epilepticus

26.5

15.6

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.7

15.6

135

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

161.3

15.5

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

5.8

15.4

CA1DG

NOMESCO Finland

Eye and orbita very extensive MRI examination with high intensity magnet

28.9

15.2

N28

ICPC

Limited function/disability (N)

3.5

15.2

147

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

23.6

15.1

WZC00, ,

SPAT

0.4

15.0

1752

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.3

14.8

Z90.0

ICD-10 Finland

Acquired absence of part of head and neck

32.0

14.8

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

3.9

14.8

112

GD1AA, ,

SPAT

0.4

14.6

1813

C69.99

ICD-10 Finland

Malignant tumor in unspecified localization in eye or other unspecified histology

+∞

14.6

C69.20

ICD-10 Finland

Retina

+∞

14.6

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

14.6

C72.9

ICD-10 Finland

Malignant neoplasm: Central nervous system, unspecified

+∞

14.6

YNB10

NOMESCO Finland

Collection of stem cells for transplant

+∞

14.6

9450/3-C71.2

ICD-O-3

Oligodendroglioma, NOS, of temporal lobe

+∞

14.6

ZX100

NOMESCO Finland

Oral

5.0

14.5

A06AH03

ATC

naloxegol; oral

10.9

14.5

M25.5

ICD-10 Finland

Pain in joint

0.6

14.3

273

4201

Z3226

NOMESCO Finland

Physiotherapist

1.7

14.1

298

1888

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.5

14.1

197

3299

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

4.8

14.0

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.5

14.0

193

3243

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.6

13.9

131

CDC00

NOMESCO Finland

Enucleation of eye

53.7

13.8

L28

ICPC

Limited function/disability (L)

1.6

13.8

343

2265

L02BA01

ATC

tamoxifen; oral

20.2

13.8

OAB43, ,

SPAT

0.6

13.7

227

3633

M79.6

ICD-10 Finland

Pain in limb

0.6

13.6

431

5914

C71.69

ICD-10 Finland

Malignant tumor of the cerebellum other or unspecified histology

+∞

13.6

9450/3-C71.3

ICD-O-3

Oligodendroglioma, NOS, of parietal lobe

+∞

13.6

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

+∞

13.6

C69.09

ICD-10 Finland

Malignant tumor in conjunctival other or unspecified histology

+∞

13.6

C71.49

ICD-10 Finland

Malignant tumor in occipital lobe other or unspecified histology

+∞

13.6

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

13.6

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

13.6

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

13.6

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.1

13.6

184

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.6

13.5

307

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.5

13.5

176

3013

D33.08

ICD-10 Finland

Another benign tumor of the cerebral ventricle

141.0

13.5

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

13.4

278

1751

XCK00

NOMESCO Finland

Perimetry

2.2

13.4

115

542

N88

ICPC

Epilepsy

5.6

13.4

TPX15

NOMESCO Finland

Removal of vascular injection port

25.9

13.4

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.9

13.4

102

OAB42, ,

SPAT

0.4

13.2

1552

D43.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Spinal cord

40.4

13.2

L03

ICPC

Low back symptom/complaint

0.6

13.1

234

3674

SPAT1153

SPAT

Removal of sutures

1.5

13.0

489

3542

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.7

13.0

508

6699

SPAT1229

SPAT

Assessment of need for aid

2.1

13.0

134

678

L13

ICPC

Hip symptom/complaint

0.5

13.0

115

2226

Z97.0

ICD-10 Finland

Presence of artificial eye

28.6

13.0

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

13.1

12.9

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

50.4

12.8

N75

ICPC

Benign neoplasm nervous system

70.3

12.6

3779

FHL

Other operations in this group include disc removal

70.3

12.6

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.6

12.5

210

3360

AA5JS

NOMESCO Finland

Extensive PET-MRI of brain metabolism

+∞

12.5

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

12.5

C71.51

ICD-10 Finland

Malignant tumor of cerebral ventricle ependymoma

+∞

12.5

9382/3-C71.9

ICD-O-3

Oligoastrocytoma, NOS, of brain, NOS

+∞

12.5

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

12.5

9470/3-C71.6

ICD-O-3

Medulloblastoma, NOS, of cerebellum, NOS

+∞

12.5

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

12.5

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

12.5

C71.42

ICD-10 Finland

Malignant tumor of the occipital lobe grade III glioma

+∞

12.5

ZXE00

NOMESCO Finland

One hour or less

1.5

12.5

607

4625

R4190

NOMESCO Finland

Nutritional therapy

2.7

12.5

255

N03AF04

ATC

eslicarbazepine; oral

130.9

12.4

YX9AW, ,

NOMESCO Finland

130.9

12.4

23810

ICD-8 Finland

Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain

130.9

12.4

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

130.9

12.4

D33.05

ICD-10 Finland

Other lateral benign tumor in temporal lobe

130.9

12.4

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

130.9

12.4

C10AA05

ATC

atorvastatin; oral

0.7

12.4

435

5877

N02AA01

ATC

morphine; systemic, rectal

4.5

12.4

R51.80

ICD-10 Finland

Headache

1.7

12.3

269

1717

CA1ME

NOMESCO Finland

Ultrasound oculometry

5.8

12.3

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

14.4

12.3

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

12.2

139

728

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.4

12.2

128

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

37.8

12.2

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

5.0

12.2

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.6

12.1

114

NK6AN

NOMESCO Finland

Total body bone isotope imaging

18.2

12.0

PA7RT

NOMESCO Finland

Medical infusion to cerebral artery

26.9

12.0

CS494

NOMESCO Finland

Other visual field testing

2.9

12.0

203

A07AA02

ATC

nystatin; oral

2.2

12.0

440

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.5

12.0

296

R41.0

ICD-10 Finland

Disorientation, unspecified

2.6

11.9

279

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.4

11.8

359

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

4.6

11.7

D33.43

ICD-10 Finland

Spinal cord

65.4

11.6

D31.6

ICD-10 Finland

Benign neoplasm: Orbit, unspecified

19.0

11.6

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

23.0

11.6

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.3

11.5

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

11.5

101

481

JJ1AQ

NOMESCO Finland

Liver SPECT with low dose CT

+∞

11.5

9591/3-C71.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS

+∞

11.5

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

11.5

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

11.5

C71.74

ICD-10 Finland

Malignant tumor of the brainstem ependyoma

+∞

11.5

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

11.5

CAW99

NOMESCO Finland

Other operation on orbit

+∞

11.5

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

+∞

11.5

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

11.5

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

11.5

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

11.5

C71.92

ICD-10 Finland

Malignant tumor in an unspecified localization in the brain grade III glioma

+∞

11.5

ZX131

NOMESCO Finland

Intrathecal

+∞

11.5

9380/3-C71.1

ICD-O-3

Glioma, malignant of frontal lobe

+∞

11.5

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.7

11.5

202

1215

R03AC02

ATC

salbutamol; inhalant

0.7

11.3

619

7737

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.5

11.3

110

N19

ICPC

Speech disorder

3.4

11.3

115

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

11.2

115

581

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

25.2

11.1

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

11.1

458

3368

AA1AA

NOMESCO Finland

Head X-ray examination

5.3

11.1

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

5.8

11.0

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

11.0

199

1206

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.2

11.0

132

H26.2

ICD-10 Finland

Complicated cataract

3.8

10.9

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

10.8

127

674

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

13.0

10.6

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.5

10.6

118

2132

X76

ICPC

Malignant neoplasm breast female

60.3

10.6

D42.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Cerebral meninges

60.3

10.6

M01AH05

ATC

etoricoxib; oral

0.7

10.6

744

8955

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.0

10.5

H53.2

ICD-10 Finland

Diplopia

2.4

10.5

284

F80.1

ICD-10 Finland

Expressive language disorder

4.1

10.4

9530/3-C70.0

ICD-O-3

Meningioma, malignant of cerebral meninges

+∞

10.4

1CD02, ,

NOMESCO Finland

+∞

10.4

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

10.4

CAD00

NOMESCO Finland

Exenteration of orbit with use of graft or flap

+∞

10.4

C69.45

ICD-10 Finland

Melanoma of iris

+∞

10.4

22500

ICD-8 Finland

Benign neoplasm of brain and other parts of nervous system, Brain

+∞

10.4

AA5FK

NOMESCO Finland

Functional assessment (fMRI) of brain

+∞

10.4

AA003

NOMESCO Finland

Adjuvant radiotherapy of brain

+∞

10.4

C69.60

ICD-10 Finland

Malignant tumor in orbit without histology

+∞

10.4

C69.0

ICD-10 Finland

Malignant neoplasm: Conjunctiva

+∞

10.4

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

10.4

XX9XW, ,

NOMESCO Finland

5.5

10.4

N02BE01

ATC

paracetamol; systemic, rectal

1.5

10.4

1538

14088

WF099

NOMESCO Finland

Other radiotherapy

23.5

10.2

WZC30, ,

SPAT

0.3

10.2

990

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.6

10.2

197

3055

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.4

10.1

283

Z31.5

ICD-10 Finland

Genetic counselling

2.3

10.1

321

R07.4

ICD-10 Finland

Chest pain, unspecified

0.6

10.1

255

3717

NA3BG, ,

SPAT

0.1

10.0

384

E23.00

ICD-10 Finland

Panhypopituitarism

10.1

10.0

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

10.0

407

SAA01

NOMESCO Finland

Simple examination of mouth

0.7

9.9

932

10775

M03BX01

ATC

baclofen; systemic

3.0

9.9

141

R83

ICPC

Respiratory infection other

0.6

9.8

198

3046

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

20.1

9.8

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

20.1

9.8

G41.0

ICD-10 Finland

Grand mal status epilepticus

20.1

9.8

WX142

NOMESCO Finland

Sub-tenon anesthesy

4.7

9.8

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

55.3

9.6

SPAT1290

SPAT

Preparation of deceased person

55.3

9.6

CH2S4

NOMESCO Finland

Photography of iris

55.3

9.6

ZXD35

NOMESCO Finland

Usual procedure

2.5

9.6

253

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

8.4

9.6

ZZR00

NOMESCO Finland

Flap of skin

8.4

9.6

CD2S4

NOMESCO Finland

Photography of eye

7.2

9.5

OAB48, ,

SPAT

0.5

9.5

1748

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.0

9.4

498

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

100.5

9.4

F74

ICPC

Neoplasm of eye/adnexa

100.5

9.4

AA5NK

NOMESCO Finland

Tractography within white matter of central nervous system

100.5

9.4

D43.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system

100.5

9.4

L02BG06

ATC

exemestane; oral

100.5

9.4

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

100.5

9.4

2396A

ICD-9 Finland

Neoplasm of unspecified nature, Brain

+∞

9.4

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

9.4

C69.63

ICD-10 Finland

Malignant tumor of orbital carcinoma

+∞

9.4

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

+∞

9.4

8720/3-C69.0

ICD-O-3

Malignant melanoma, NOS, of conjunctiva

+∞

9.4

9380/3-C71.2

ICD-O-3

Glioma, malignant of temporal lobe

+∞

9.4

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

9.4

3AA13, ,

NOMESCO Finland

+∞

9.4

C71.79

ICD-10 Finland

Malignant tumor of the brainstem other or unspecified histology

+∞

9.4

L01CB01

ATC

etoposide; systemic

+∞

9.4

D43

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of brain and central nervous system

+∞

9.4

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

9.4

9400/3-C71.0

ICD-O-3

Astrocytoma, NOS, of cerebrum

+∞

9.4

C69.2

ICD-10 Finland

Malignant neoplasm: Retina

+∞

9.4

C71.63

ICD-10 Finland

Malignant tumor of cerebellum grade IV glioma

+∞

9.4

C69.29

ICD-10 Finland

Retina

+∞

9.4

19003

ICD-8 Finland

Malignant neoplasm of eye, Retinae

+∞

9.4

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

9.4

C71.61

ICD-10 Finland

Malignant tumor of cerebellum grade II glioma

+∞

9.4

8000/3-C71.1

ICD-O-3

Neoplasm, malignant of frontal lobe

+∞

9.4

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

9.4

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

9.4

1905A

ICD-9 Finland

Malignant neoplasm of eye, Retina[RETINOBLASTOMA RETINAE]

+∞

9.4

C50

ICD-10 Finland

Malignant neoplasm of breast

+∞

9.4

9391/3-C71.7

ICD-O-3

Ependymoma, NOS, of brain stem

+∞

9.4

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

9.4

L15

ICPC

Knee symptom/complaint

0.6

9.3

211

3163

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

9.3

111

592

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

8.7

9.3

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.4

9.3

282

OAA67, ,

SPAT

0.5

9.1

101

1830

SDA03

NOMESCO Finland

Periodontal treatment

0.7

9.1

402

5274

M54.4

ICD-10 Finland

Lumbago with sciatica

0.6

9.0

126

2134

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

9.1

9.0

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

36.9

9.0

A10AB05

ATC

insulin aspart; parenteral

1.8

9.0

140

812

OAA80, ,

SPAT

0.4

9.0

1129

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

18.7

8.9

NG1AA, ,

SPAT

0.3

8.9

840

EB1VA, ,

NOMESCO Finland

0.6

8.9

123

2086

1XC02, ,

NOMESCO Finland

8.0

8.8

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.6

8.8

149

2396

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

8.7

139

812

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

8.7

167

1029

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

8.6

479

I10

ICD-10 Finland

Essential (primary) hypertension

0.7

8.6

759

8950

AAF00

NOMESCO Finland

Ventriculostomy

4.4

8.6

G06.0

ICD-10 Finland

Intracranial abscess and granuloma

16.4

8.5

H01AC01

ATC

somatropin; parenteral

7.0

8.5

R11

ICD-10 Finland

Nausea and vomiting

1.8

8.5

139

818

N29

ICPC

Neurological sympt/complt other

2.8

8.5

148

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.0

8.5

468

M54.5

ICD-10 Finland

Low back pain

0.7

8.5

359

4756

D33.4

ICD-10 Finland

Benign neoplasm: Spinal cord

27.6

8.5

D33.2

ICD-10 Finland

Benign neoplasm: Brain, unspecified

27.6

8.5

N03AX11

ATC

topiramate; oral

2.7

8.5

171

XX8XW, ,

NOMESCO Finland

20.1

8.5

D33.41

ICD-10 Finland

Myxopapillary epndymoma of the spinal cord (grade I)

90.5

8.4

2159

FHL

Other measure in this category

90.5

8.4

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

8.4

108

1871

NB1AA, ,

SPAT

0.2

8.4

421

C01DA14

ATC

isosorbide mononitrate; oral

0.6

8.4

115

1957

ZX000

NOMESCO Finland

Simple adjustment of radiotherapy with simulator or with therapeutic device - isocentric therapy

+∞

8.3

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

8.3

AAF30

NOMESCO Finland

Implantation of intraventricular injection device

+∞

8.3

C69.91

ICD-10 Finland

Malignant tumor in unspecified localization in the eye retinoblastoma

+∞

8.3

D33.03

ICD-10 Finland

Pilosytic lateral astrocytoma of the strobe brain

+∞

8.3

1911X

ICD-9 Finland

Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,EI HISTOLOGISTA VAHVISTUST]

+∞

8.3

C71.73

ICD-10 Finland

Malignant tumor of the brain stem grade IV glioma

+∞

8.3

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

8.3

C72.3

ICD-10 Finland

Malignant neoplasm: Optic nerve

+∞

8.3

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

+∞

8.3

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

8.3

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

8.3

C70.9

ICD-10 Finland

Malignant neoplasm: Meninges, unspecified

+∞

8.3

D33.10

ICD-10 Finland

Benign pilosytic astrocytoma of brain stem

+∞

8.3

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

+∞

8.3

8000/3-C71.2

ICD-O-3

Neoplasm, malignant of temporal lobe

+∞

8.3

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

8.3

L03AB05

ATC

interferon alfa-2b; parenteral

+∞

8.3

9445/3-C71.9

ICD-O-3

Glioblastoma, IDH-mutant of brain, NOS

+∞

8.3

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

8.3

D42.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Meninges, unspecified

+∞

8.3

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

8.6

8.3

C07AB07

ATC

bisoprolol; oral

0.7

8.3

556

6838

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

9.5

8.3

XX2XW

NOMESCO Finland

Other teleradiological consultation

9.5

8.3

PA6AD

NOMESCO Finland

CT of neck arteries

2.2

8.3

336

ZX121

NOMESCO Finland

Central venous catheter

14.5

8.2

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

14.5

8.2

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

7.6

8.2

G91.0

ICD-10 Finland

Communicating hydrocephalus

4.6

8.1

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

4.6

8.1

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

11.7

8.1

SPAT1109

SPAT

Analgesia with portable analgesic pump

11.7

8.1

CBA10

NOMESCO Finland

Biopsy of eyelid

6.3

8.0

A10BK03

ATC

empagliflozin; oral

0.5

8.0

1197

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

7.9

396

S18

ICPC

Laceration/cut

1.3

7.9

730

6077

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

7.8

198

2905

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.0

7.8

398

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

7.8

441

AAA00

NOMESCO Finland

Exploratory craniotomy

45.2

7.7

102

Kela drug reimbursment

Diabetes insipidus

15.1

7.7

H47.1

ICD-10 Finland

Papilloedema, unspecified

6.4

7.7

EB4VA, ,

NOMESCO Finland

0.6

7.6

119

1956

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

25.1

7.6

D33.40

ICD-10 Finland

Benign glioma of the spinal cord (grade I)

25.1

7.6

WPA44

NOMESCO Finland

Nursing home for palliative care

25.1

7.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

7.5

106

597

R74

ICPC

Upper respiratory infection acute

0.7

7.5

301

4042

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

7.5

329

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

3.0

7.5

103

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

3.6

7.4

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

80.4

7.4

C90.0

ICD-10 Finland

Multiple myeloma

80.4

7.4

H05.9

ICD-10 Finland

Disorder of orbit, unspecified

80.4

7.4

CAB00

NOMESCO Finland

Anterior orbitotomy with excision of lesion

80.4

7.4

WX1BG

NOMESCO Finland

Total body MRI with high intensity magnet

80.4

7.4

2377A

ICD-9 Finland

Neoplasm of uncertain behaviour of endocrine glands and nervous system, Neurofibromatosis

80.4

7.4

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

13.4

7.4

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

7.4

1673

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

7.3

380

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

7.3

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

+∞

7.3

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

7.3

C69.90

ICD-10 Finland

Malignant tumor in unspecified localization in eye without histology

+∞

7.3

9400/3-C71.3

ICD-O-3

Astrocytoma, NOS, of parietal lobe

+∞

7.3

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

7.3

9591/3-C69.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of eye, NOS

+∞

7.3

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

7.3

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

7.3

C72.0

ICD-10 Finland

Malignant neoplasm: Spinal cord

+∞

7.3

9382/3-C71.2

ICD-O-3

Oligoastrocytoma, NOS, of temporal lobe

+∞

7.3

1BC01, ,

NOMESCO Finland

+∞

7.3

L02AE04

ATC

triptorelin; parenteral

+∞

7.3

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

7.3

C71.41

ICD-10 Finland

Malignant tumor of occipital lobe grade II glioma

+∞

7.3

19107

ICD-8 Finland

Malignant neoplasm of brain, Cerebelli

+∞

7.3

C69.4

ICD-10 Finland

Malignant neoplasm: Ciliary body

+∞

7.3

QX2AN

NOMESCO Finland

Other soft tissue tumour isotope imaging

+∞

7.3

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

7.3

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

+∞

7.3

D43.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Cranial nerves

+∞

7.3

C71.04

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles ependyoma

+∞

7.3

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

7.3

WW402

NOMESCO Finland

Leucoferesis

+∞

7.3

CKA10

NOMESCO Finland

Biopsy of vitreous body

10.9

7.3

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

10.9

7.3

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

10.9

7.3

N03AX09

ATC

lamotrigine; oral

2.0

7.3

409

207

Kela drug reimbursment

Chronic arrhythmias

0.6

7.2

110

1824

Q85.09

ICD-10 Finland

Unspecified neurofibromatosis

15.8

7.2

ZX108

NOMESCO Finland

Inhalation

5.8

7.2

R03DC03

ATC

montelukast; oral

0.6

7.2

111

1834

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.8

7.2

122

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

20.1

7.1

L08

ICPC

Shoulder symptom/complaint

0.7

7.1

200

2876

R05

ICPC

Cough

0.7

7.1

217

3068

SAA02

NOMESCO Finland

Basic examination of mouth

0.8

7.1

850

9724

WPA13

NOMESCO Finland

Palliative consultation

12.1

7.1

XF600, ,

SPAT

0.2

7.1

342

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.5

7.0

1208

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.3

7.0

673

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

7.0

291

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.0

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

7.0

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.4

7.0

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.7

7.0

266

3608

A10BA02

ATC

metformin; oral

0.7

6.9

277

3728

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.7

6.9

136

ZXY02

NOMESCO Finland

Neuropsychologist

5.9

6.9

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

7.6

6.9

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.8

6.9

107

622

DFF20

NOMESCO Finland

Audiometry for children

11.0

6.8

WPA11

NOMESCO Finland

Developing a plan for palliative care

40.2

6.8

3102

FHL

Enucleation

40.2

6.8

N05AD01

ATC

haloperidol; systemic

2.2

6.7

256

R053, ,

ICD-10 Finland

0.2

6.7

312

Z71.8

ICD-10 Finland

Other specified counselling

0.7

6.6

324

4220

L17

ICPC

Foot/toe symptom/complaint

0.7

6.6

295

3901

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

3.1

6.6

G83.9

ICD-10 Finland

Paralytic syndrome, unspecified

12.3

6.6

N03AX15

ATC

zonisamide; oral

8.7

6.6

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.8

6.5

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

10.1

6.5

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

2.8

6.5

112

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

6.2

6.5

S01EA03

ATC

apraclonidine; ophthalmic

3.5

6.4

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

70.1

6.4

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

70.1

6.4

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

70.1

6.4

AA5GG

NOMESCO Finland

Extensive functional MRI examination of brain withhigh intensity magnet

70.1

6.4

WPA40

NOMESCO Finland

Individual-centered psychosocial intervention in palliative care

70.1

6.4

N05BA01

ATC

diazepam; systemic, rectal

1.5

6.4

196

1348

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

14.4

6.4

B01AB04

ATC

dalteparin; parenteral

2.0

6.4

330

N06DX01

ATC

memantine; oral

0.4

6.3

860

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

6.3

9401/3-C71.3

ICD-O-3

Astrocytoma, anaplastic, NOS, of parietal lobe

+∞

6.3

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

6.3

1922A

ICD-9 Finland

Malignant neoplasm of other and unspecified parts of nervous system, Spinal cord

+∞

6.3

D33.12

ICD-10 Finland

Cerebellum

+∞

6.3

19100

ICD-8 Finland

Malignant neoplasm of brain, Lobi frontalis

+∞

6.3

9424/3-C71.9

ICD-O-3

Pleomorphic xanthoastrocytoma, NOS, of brain, NOS

+∞

6.3

C71.66

ICD-10 Finland

Malignant tumor of the cerebellum medullobastoma

+∞

6.3

C69.69

ICD-10 Finland

Malignant tumor in orbital other or unspecified histology

+∞

6.3

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

6.3

AX099

NOMESCO Finland

Radiotherapy of whole central nervous system

+∞

6.3

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

6.3

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

6.3

C83.89

ICD-10 Finland

Other types of diffuse non-Hodgkin's lymphoma

+∞

6.3

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

+∞

6.3

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

6.3

D33.0

ICD-10 Finland

Benign neoplasm: Brain, supratentorial

+∞

6.3

9382/3-C71.3

ICD-O-3

Oligoastrocytoma, NOS, of parietal lobe

+∞

6.3

1911A

ICD-9 Finland

Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,ASTROCYTOMA (GR I-II)]

+∞

6.3

19109

ICD-8 Finland

Malignant neoplasm of brain, Unspecified

+∞

6.3

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

+∞

6.3

C76.0

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Head, face and neck

+∞

6.3

C71.62

ICD-10 Finland

Malignant tumor of cerebellum grade III glioma

+∞

6.3

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

6.3

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

6.3

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

+∞

6.3

CCA10

NOMESCO Finland

Biopsy of lacrimal gland

+∞

6.3

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

6.3

9445/3-C71.1

ICD-O-3

Glioblastoma, IDH-mutant of frontal lobe

+∞

6.3

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

6.3

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

6.3

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

6.3

WPA42

NOMESCO Finland

Family-centered psychosocial intervention in palliative care

+∞

6.3

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

6.3

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

6.3

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

6.3

1AC01, ,

NOMESCO Finland

+∞

6.3

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

6.3

2312

FHL

Extirpation or destruction

+∞

6.3

WX1DG

NOMESCO Finland

Very extensive total body MRI with high intensity magnet

+∞

6.3

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

6.3

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

6.3

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

2.6

6.2

126

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

26.8

6.2

KCD02

NOMESCO Finland

Transurethral resection of bladder

7.0

6.2

H47.2

ICD-10 Finland

Optic atrophy

7.0

6.2

Z31.6

ICD-10 Finland

General counselling and advice on procreation

3.7

6.2

F51.0

ICD-10 Finland

Nonorganic insomnia

0.6

6.2

118

1850

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

4.0

6.2

R01AD12

ATC

fluticasone furoate; nasal

0.7

6.1

286

3758

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.4

6.1

176

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

12.6

6.1

E23.2

ICD-10 Finland

Diabetes insipidus

12.6

6.1

H05.2

ICD-10 Finland

Exophthalmic conditions

8.6

6.1

Q85.00

ICD-10 Finland

Neurofibromatosis, type 1

10.1

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

351

48.28

307.65

1.8

2.1

—

(4035726) Immunohistochemistry procedure

845

392

38.39

307.65

1.4

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

154

111.75

300.78

1.1

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

269

+∞

288.14

1.0

0.0

—

(3003396) Base excess in Arterial blood by calculation

676

1734

5.53

258.75

7.5

8.4

1.09

1.05

mmol/l

0.10

538

1422

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

676

1747

5.48

256.23

7.7

8.4

5.00

5.08

kpa

1.86

653

1682

(3027801) Oxygen [Partial pressure] in Arterial blood

676

1747

5.48

256.23

7.7

8.4

17.32

11.63

kpa

76.15

653

1681

(3019977) pH of Arterial blood

675

1746

5.48

255.50

7.7

8.4

7.42

0.74

440

986

(3018677) aPTT in Platelet poor plasma by Coagulation assay

740

2285

4.70

221.18

2.3

2.2

27.35

29.71

18.93

721

2226

(40768804) Tissue Pathology biopsy report

1065

4720

3.90

184.60

3.1

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

100

55.54

176.20

1.6

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

985

4345

3.67

167.64

2.7

2.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1346

7301

3.98

165.15

14.6

4.1

10.50

12.42

umol/l

7.20

1328

6886

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

154

+∞

162.93

1.1

0.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

168

157

11.65

157.85

2.0

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

226

336

7.51

147.71

2.0

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

845

3609

3.44

146.86

4.4

3.9

93.34

88.31

8.20

821

3532

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

234

374

7.01

142.94

2.1

1.5

2553.44

1314.30

e6/l

0.57

183

299

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

232

371

6.99

141.62

2.0

1.4

58.36

33.88

e6/l

0.41

177

285

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

791

3331

3.38

139.18

2.6

2.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1207

6564

3.35

137.06

8.7

6.3

1.20

1.21

mmol/l

10.57

1176

5983

(42870588) Differential panel, method unspecified - Blood

999

4946

3.18

131.71

10.7

5.8

—

(3016018) Differential panel - Cerebral spinal fluid

161

184

9.48

130.65

1.9

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

111

15.46

125.43

2.4

2.6

53.10

53.80

umol/l

0.06

101

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1259

7359

3.16

119.56

9.4

6.5

1.20

1.21

mmol/l

7.74

1134

6352

(3013650) Neutrophils [#/volume] in Blood by Automated count

1354

8261

3.29

119.01

20.2

6.9

4.05

4.26

e9/l

2.60

1181

7078

(3002173) Hemoglobin [Mass/volume] in Arterial blood

447

1435

3.78

117.98

8.9

9.3

127.33

123.59

g/l

3.56

436

1404

(3016502) Oxygen saturation in Arterial blood

464

1550

3.65

115.13

8.9

8.8

97.69

95.05

20.39

451

1497

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

210

373

6.21

115.05

1.8

1.2

3.66

3.84

mmol/l

1.11

203

358

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

421

1344

3.75

111.53

5.5

2.5

243.02

233.73

u/l

0.74

411

1267

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1120

6467

2.81

102.56

3.3

2.5

—

estimate

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1391

9006

3.10

102.38

9.0

4.9

6.72

6.75

mmol/l

0.20

1366

8513

(3011412) CD3 cells [#/volume] in Blood

104

11.41

97.99

2.0

2.5

1080.59

1333.01

e6/l

1.32

(3019069) Monocytes/Leukocytes in Blood

1164

6982

2.76

96.72

11.3

6.1

8.90

8.87

0.15

1145

6520

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

12.59

96.59

1.7

1.9

—

(3006504) Eosinophils/Leukocytes in Blood

1158

6975

2.72

94.61

11.2

6.0

2.01

2.96

43.02

1136

6506

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

14.21

94.24

1.9

2.5

—

(3022096) Basophils/Leukocytes in Blood

1152

6984

2.68

91.82

11.3

6.1

0.52

0.68

20.65

1132

6511

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

924

5048

2.64

91.07

2.7

2.2

173.12

246.09

u/l

1.66

901

4775

(3001604) Monocytes [#/volume] in Blood

1222

7674

2.70

89.82

11.2

5.9

0.56

0.59

e9/l

5.54

1044

6572

(3002030) Lymphocytes/Leukocytes in Blood

1165

7164

2.65

89.13

11.4

6.0

24.00

28.07

29.80

1148

6774

(3006315) Basophils [#/volume] in Blood

1221

7691

2.68

88.73

11.2

5.9

0.03

0.04

e9/l

26.32

1043

6591

(3018010) Neutrophils/Leukocytes in Blood

1146

7048

2.61

86.71

11.0

6.0

60.97

57.08

20.65

1132

6719

(3012095) Magnesium [Moles/volume] in Serum or Plasma

537

2283

2.89

86.08

4.3

3.1

0.84

0.83

mmol/l

1.17

515

2132

(3013115) Eosinophils [#/volume] in Blood

1239

7956

2.64

84.89

11.8

6.1

0.13

0.20

e9/l

55.51

1063

6920

(3019198) Lymphocytes [#/volume] in Blood

1225

7845

2.62

84.03

11.3

6.0

1.60

1.90

e9/l

5.23

1057

6876

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

101

119

8.91

79.61

1.9

1.3

2.36

2.11

mmol/l

0.88

112

(3023368) Bacteria identified in Blood by Culture

754

3937

2.53

78.90

4.7

3.9

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

859

4766

2.48

78.74

9.0

2.1

2.36

2.35

mmol/l

0.63

816

4222

(40768795) Lymph node Pathology biopsy report

25.44

74.06

1.3

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1025

6309

2.38

72.48

6.4

4.2

34.88

36.15

g/l

9.81

984

5869

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

264

825

3.56

70.28

11.6

12.0

17.04

16.07

5.68

252

798

(3023410) Appearance of Cerebral spinal fluid

115

184

6.59

69.33

2.0

1.6

—

(3018418) pH of Serum or Plasma

765

4236

2.36

67.91

4.3

3.4

7.41

7.40

6.14

537

3013

(3032080) INR in Blood by Coagulation assay

1065

6826

2.29

66.28

9.2

16.2

1.13

1.29

inr

25.40

920

5723

(3036481) Cortisol [Moles/volume] in Serum or Plasma

356

1414

2.87

62.81

2.8

1.9

320.65

363.76

nmol/l

4.46

339

1305

(3000991) Gas panel - Venous blood

348

1368

2.90

62.57

7.4

9.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1482

11350

2.45

54.96

16.7

5.8

75.20

77.23

u/l

1.17

1450

10650

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

337

6723

0.39

53.67

1.9

1.37

1.38

mmol/l

0.14

295

5697

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

8.96

52.82

2.0

2.3

523.54

478.18

e6/l

0.21

(3003694) ABO and Rh group [Type] in Blood

706

4102

2.16

52.61

1.3

1.4

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

9.82

52.34

2.2

1.1

63.61

62.00

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

8.94

51.93

2.0

2.4

182.51

236.97

e6/l

1.13

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

8.13

51.74

1.3

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

8.43

48.08

1.3

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

13.15

46.96

1.6

2.3

38.82

24.20

5.22

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1265

15277

0.47

46.63

4.0

5.2

4.68

4.58

mmol/l

2.68

1168

14371

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1291

15478

0.47

46.53

4.4

5.9

2.80

2.69

mmol/l

4.06

1191

14515

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1257

15190

0.48

45.62

3.9

5.1

1.40

1.42

mmol/l

0.99

1161

14199

(3014111) Lactate [Moles/volume] in Serum or Plasma

315

1374

2.55

45.14

6.9

8.4

1.31

1.39

mmol/l

0.94

309

1344

(3045142) Bone marrow Pathology biopsy report

9.39

44.94

1.3

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

9.11

44.70

3.5

2.8

28.24

31.10

umol/l

0.84

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

8.46

42.94

2.1

2.5

37.32

46.27

2.66

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1194

14606

0.50

42.68

5.1

6.5

38.70

39.55

mmol/mol

2.83

1118

13747

(3020779) Urea [Moles/volume] in Serum or Plasma

308

1364

2.51

42.59

4.4

7.7

6.35

9.78

mmol/l

21.92

291

1303

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

11.53

42.33

2.1

1.1

22.44

19.71

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

94.32

41.95

1.3

1.0

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

177

5.11

40.61

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

109

267

4.27

40.54

3.2

5.8

350.77

358.67

umol/l

0.21

101

241

(3039000) Anion gap in Blood by calculation

113

289

4.10

39.68

16.4

7.4

10.63

11.49

mmol/l

2.33

101

260

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

461

2492

2.13

39.52

2.1

1.8

—

(3018572) Chloride [Moles/volume] in Blood

113

290

4.08

39.49

16.4

7.4

106.03

105.24

mmol/l

0.72

101

261

(3021589) Normoblasts [#/volume] in Blood

966

6758

1.88

38.90

19.3

9.7

0.00

e9/l

0.79

765

5484

(3008152) Bicarbonate [Moles/volume] in Arterial blood

234

960

2.64

37.68

12.8

6.8

25.35

24.55

mmol/l

2.58

220

923

(3019060) Gas panel - Arterial blood

225

906

2.69

37.60

10.3

4.9

—

(3017181) Myelocytes/Leukocytes in Blood

273

1213

2.46

37.18

5.3

4.3

1.70

0.67

9.46

165

266

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

6.80

36.22

1.1

1.53

1.08

u/l

1.41

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

103

266

4.04

35.67

3.8

6.6

558.06

412.85

iu/ml

0.16

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

484

2755

2.02

35.59

4.2

2.1

2.45

2.44

mmol/l

1.55

450

2419

(3004809) Band form neutrophils/Leukocytes in Blood

153

5.06

34.89

3.8

2.3

2.04

1.22

0.89

132

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

182

688

2.82

34.26

2.5

1.6

2.98

2.74

ug/l

0.36

132

516

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

154

4.89

32.66

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

11.15

32.05

4.7

2.6

2.01

0.92

1.87

(40758558) Short blood count panel - Blood

674

4413

1.82

31.70

13.3

4.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1219

14487

0.55

31.51

3.5

4.4

1.32

1.31

mmol/l

0.29

1124

13412

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

343

1791

2.12

31.45

2.0

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

357

1900

2.09

31.10

2.0

1.8

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

7.23

31.01

1.2

847.53

111.99

ng/l

0.73

(3021879) Hepatitis B virus core Ab [Presence] in Serum

235

1057

2.40

30.89

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

628

4103

1.80

29.23

3.0

3.1

0.46

0.39

e6/l

0.24

459

2994

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

149

561

2.80

28.16

1.9

2.2

309.93

455.80

ug/l

0.51

142

529

(3008757) Leukocyte morphology finding [Identifier] in Blood

5.59

27.80

3.8

2.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

7.64

27.64

1.4

1.1

—

(3002179) Metamyelocytes/Leukocytes in Blood

244

1172

2.24

27.39

5.0

4.0

1.24

0.52

3.33

138

263

(3047181) Lactate [Moles/volume] in Blood

128

455

2.95

26.88

15.1

6.0

1.71

1.30

mmol/l

1.79

114

404

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

108

5.22

26.72

1.1

607.41

261.41

mg/l

1.17

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

114

5.03

26.12

1.1

1.2

78.66

36.53

mg/l

0.79

(3005719) IgG [Mass/volume] in Serum or Plasma

225

1065

2.26

26.11

3.0

2.5

8.73

10.79

g/l

13.84

210

994

(3021440) Promyelocytes/Leukocytes in Blood

241

1178

2.20

25.85

5.5

4.4

0.24

0.05

4.07

134

230

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1276

14780

0.57

25.81

4.5

5.1

5.89

5.98

mmol/l

1.67

1166

13622

(3042111) Morphology [Interpretation] in Bone marrow Narrative

120

4.87

25.58

1.5

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

177

769

2.44

24.96

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

281

3.39

24.92

2.3

2.2

21.11

29.85

u/ml

0.21

235

(3002582) Erythrocytes [#/volume] in Urine

688

4794

1.69

24.46

3.1

3.2

31.59

77.94

e6/l

2.00

509

3638

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

133

4.55

24.39

1.6

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

5.67

24.03

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

109

378

3.00

23.91

1.8

1.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

112

4.84

23.68

2.7

2.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

113

403

2.92

23.58

3.1

4.2

0.42

0.37

iu/ml

0.78

228

(1761868) Lipid panel - Serum or Plasma

397

6123

0.55

23.56

2.7

3.2

—

(3026008) Bacteria identified in Urine by Culture

621

4276

1.68

22.72

3.0

3.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

146

611

2.51

22.28

14.9

5.2

1.03

0.85

6.95

134

578

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

155

672

2.42

21.92

14.3

4.9

1.56

1.68

0.78

143

639

(3012516) Albumin [Mass/volume] in Urine

339

5381

0.55

21.79

3.2

3.6

62.66

46.08

mg/l

0.66

223

3511

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

381

2313

1.81

21.71

2.7

3.0

1.98

2.31

e6/l

0.31

172

1092

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

109

4.69

21.54

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

295

1657

1.93

21.45

1.5

1.7

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

5.10

21.44

1.4

1.2

0.49

0.53

ratio

0.83

(3031040) Bacteria [#/volume] in Urine by Automated count

1179

9592

1.62

21.35

4.6

4.4

2974.93

1819.08

e6/l

0.16

132

(3020682) Albumin/Creatinine [Ratio] in Urine

350

5449

0.56

20.75

3.8

4.3

10.50

8.36

mg/mmol

0.43

209

3470

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

406

2547

1.76

20.58

2.6

2.8

1.15

1.06

e6/l

0.15

200

1335

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

141

4.06

20.10

3.8

2.9

16.82

19.55

nmol/l

1.10

130

(3000060) B lymphocytes [#/volume] in Blood

8.04

20.04

2.3

2.5

0.37

0.39

e9/l

0.04

(3009508) Creatinine [Moles/volume] in Urine

381

5756

0.58

20.03

3.3

3.6

8.17

7.88

mmol/l

0.50

314

4923

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

283

1602

1.90

20.02

2.8

2.5

7.52

7.77

umol/l

0.08

240

1400

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

347

2102

1.80

19.75

1.5

1.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

334

2.88

19.17

1.9

3.1

33.32

36.94

umol/l

0.50

306

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

695

5084

1.58

19.13

5.5

2.8

33.13

36.72

u/l

0.45

671

4791

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

5.46

18.57

1.3

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

183

921

2.09

18.01

1.6

—

(3026782) Osmolality of Urine

428

2815

1.67

17.97

2.8

2.7

528.34

532.29

mosm/kgh2o

0.15

385

2442

(3012501) Base excess in Blood by calculation

272

2.99

17.57

2.5

4.4

2.41

2.59

mmol/l

0.26

168

(3003458) Phosphate [Moles/volume] in Serum or Plasma

324

1993

1.76

17.31

4.6

6.0

1.01

1.04

mmol/l

1.22

306

1837

(3037121) Protein [Mass/volume] in Urine

118

508

2.41

16.93

6.3

3.7

193.41

427.45

mg/l

1.09

198

(3025159) Blasts/Leukocytes in Blood

219

1206

1.92

16.70

5.6

4.5

0.12

0.01

1.91

110

217

(3036489) Thrombin time

126

564

2.32

16.55

2.6

2.2

22.01

20.92

0.85

113

503

(40768441) Liver Pathology biopsy report

5.15

16.49

1.1

1.8

—

(3008295) Osmolality of Serum or Plasma

164

3.49

16.24

1.3

1.5

281.34

278.50

mosm/kgh2o

0.36

122

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

302

2.79

16.16

1.4

1.7

—

(3018095) Leukocytes [#/volume] in Urine

724

5508

1.51

15.90

3.8

48.99

98.70

e6/l

2.77

515

3810

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

346

2.65

15.81

2.0

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

112

4.00

15.61

1.7

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

147

3.54

15.16

1.4

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

143

2666

0.50

14.55

1.3

17.57

9.24

u/ml

0.60

1038

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

335

2.58

14.20

2.0

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

6.28

13.75

1.3

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

164

2875

0.53

13.65

1.3

23.95

32.36

iu/ml

0.77

845

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

213

2.93

13.29

2.2

1.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

19.18

12.91

1.6

3.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1271

14174

0.68

12.84

5.0

5.1

1.76

1.91

mu/l

5.85

1181

13113

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

305

2.55

12.70

1.3

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

305

2.55

12.70

1.3

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

553

7138

0.68

12.52

2.8

3.0

195.60

120.10

ug/l

2.74

513

6661

(3002256) Pathology report gross observation

202

1197

1.77

12.09

1.3

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

172

3.02

11.84

2.0

1.6

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

+∞

11.47

1.1

0.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

197

1179

1.75

11.38

2.1

2.2

0.23

0.21

g/l

2.65

187

1085

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

5.05

11.00

1.2

—

(3042936) Bacteria identified in Isolate by Culture

306

2070

1.57

10.95

1.7

2.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

108

538

2.07

10.93

1.9

1.7

0.88

1.68

ug/l

0.93

470

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

9.64

10.75

1.7

1.9

14.41

76.20

u/l

0.51

(3028026) IgM [Mass/volume] in Serum or Plasma

149

845

1.83

10.31

2.2

1.5

1.45

1.17

g/l

0.67

142

789

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

23.49

10.24

1.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

742

6021

1.38

10.19

3.7

3.8

30.91

69.79

ng/l

2.06

575

4216

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.05

10.05

1.0

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

225

1442

1.64

10.05

4.6

3.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

450

3353

1.45

10.04

8.2

4.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

7.66

9.90

2.4

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

4.28

9.85

1.1

1.0

—

(40765096) Chromosome analysis panel by Banding

8.78

9.78

1.3

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

373

2695

1.48

9.72

1.6

2.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

5.04

9.57

1.6

3.4

34.00

42.95

0.83

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

174

2.74

9.28

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

440

2.07

9.22

2.3

3.0

—

(3035933) Granulocytes/Leukocytes in Blood

284

2.33

9.12

4.5

2.8

56.62

57.61

0.18

284

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.62

9.12

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.80

9.07

1.2

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

11.52

9.06

1.3

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

160

965

1.72

8.98

1.8

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

189

2.64

8.95

1.6

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

189

2.64

8.95

1.6

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

189

2.64

8.95

1.6

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

189

2.64

8.95

1.6

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

312

2.26

8.95

1.3

1.5

—

(3002032) Base excess in Venous blood by calculation

242

1627

1.56

8.81

4.9

3.8

2.14

1.84

mmol/l

0.89

215

1405

(3010813) Leukocytes [#/volume] in Blood

1590

16766

0.66

8.78

42.1

20.7

6.92

6.73

e9/l

2.40

1554

16331

(3021447) Carbon dioxide [Partial pressure] in Venous blood

246

1662

1.55

8.76

4.9

3.8

5.67

5.83

kpa

2.00

239

1615

(3000963) Hemoglobin [Mass/volume] in Blood

1590

16765

0.66

8.76

42.7

20.8

133.51

137.63

g/l

24.51

1579

16566

(3026361) Erythrocytes [#/volume] in Blood

1590

16762

0.66

8.70

42.1

20.6

4.40

4.56

e12/l

29.25

1553

16330

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1590

16762

0.66

8.70

42.9

21.1

39.75

41.45

4.70

1577

16555

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

413

3101

1.43

8.69

3.4

4.0

148.81

552.37

ng/l

3.52

316

2436

(3035941) MCH [Entitic mass]

1590

16761

0.66

8.67

42.0

20.6

30.70

30.35

12.89

1576

16561

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1590

16759

0.66

8.63

42.1

20.6

91.60

90.90

8.47

1577

16560

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

4.58

8.59

1.2

1.0

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

4.79

8.59

3.4

6.8

8.00

7.57

0.11

(3007461) Platelets [#/volume] in Blood

1590

16754

0.67

8.52

42.2

20.7

233.50

247.12

e9/l

11.75

1557

16380

(1616796) Gas panel - Central venous blood

306

2.23

8.50

2.3

3.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

821

9561

0.75

8.50

2.8

3.0

—

(3035715) Granulocytes [#/volume] in Blood

225

2.44

8.44

4.1

3.1

4.60

4.16

e9/l

0.51

225

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.48

8.37

1.2

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

169

1055

1.66

8.35

5.6

3.0

1.22

1.23

mmol/l

0.11

156

884

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

+∞

8.34

1.3

0.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

8.34

1.0

0.0

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

8.57

8.30

1.9

1.1

62.80

56.89

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

233

2.40

8.30

1.4

1.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

571

6982

0.74

8.14

2.0

2.1

93.48

95.76

pmol/l

0.60

314

3678

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.77

8.12

1.2

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

257

1785

1.51

8.04

1.6

1.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

303

2.19

7.87

1.6

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

172

2.60

7.87

2.1

1.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

439

1.98

7.86

2.3

1.5

7.28

7.41

u/l

0.04

355

(3012544) pH of Venous blood

243

1679

1.51

7.79

5.0

3.8

7.39

7.38

2.47

142

968

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1060

11830

0.76

7.58

4.5

4.1

14.69

14.78

pmol/l

0.46

980

10859

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

3.13

7.57

1.5

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

428

3308

1.38

7.48

2.7

2.6

5.48

5.55

e6/l

0.03

398

2991

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1298

0.50

7.45

1.6

1.8

3.49

3.51

mmol/l

0.08

917

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

7.29

1.1

0.0

—

(3052851) Hemolysis interference index of Serum or Plasma

409

1.97

7.27

3.4

3.3

2.14

1.95

index

0.11

211

(3020191) Ethanol [Moles/volume] in Serum or Plasma

134

2.72

7.10

1.6

1.4

1.09

1.27

promille

0.25

103

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

284

2.15

7.03

1.9

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

137

850

1.66

6.95

3.0

3.2

4.28

4.59

pmol/l

2.46

123

760

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

503

1.85

6.90

1.9

1.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

580

6959

0.76

6.87

2.3

2.5

74.77

76.85

nmol/l

0.99

534

6249

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

8.29

6.82

1.1

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

167

1094

1.58

6.80

2.2

2.5

10.59

19.77

au/ml

—

110

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

12.29

6.58

1.2

1.6

—

(21494434) Karyotype in Bone marrow

3.47

6.57

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

233

2.22

6.54

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

619

0.33

6.52

1.2

1.46

1.49

g/l

0.26

619

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

436

1.87

6.36

1.3

1.2

—

(3019225) pH of Specimen

195

1344

1.50

6.31

4.1

3.6

7.38

7.35

1.38

168

903

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

110

1754

0.60

6.20

1.8

2.0

3.50

3.60

ratio

0.41

1377

(3027945) Reticulocytes/Erythrocytes in Blood

231

1655

1.45

6.16

3.0

2.4

1.80

1.76

0.24

218

1477

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

286

2.06

6.15

1.3

1.5

102.67

136.16

au/ml

0.93

101

(3024354) Oxygen [Partial pressure] in Venous blood

201

1408

1.48

6.01

5.3

3.3

4.76

4.60

kpa

0.46

196

1364

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

103

1648

0.60

5.88

1.4

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

6.40

5.86

1.2

1.0

—

(21494755) Public health laboratory ask at order entry panel

1518

0.59

5.76

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.54

5.63

1.1

—

(40758292) HTLV I+II Ab panel - Serum

7.54

5.63

1.4

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

132

1974

0.64

5.62

2.5

219.06

144.99

ug/g

0.66

110

1592

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

275

3588

0.73

5.58

1.2

1.3

2.49

1.66

u/ml

0.31

999

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

373

4647

0.75

5.53

3.5

3.6

22.37

24.03

1.17

173

2015

(3021960) Folate [Moles/volume] in Serum or Plasma

352

4415

0.75

5.47

1.6

1.7

18.83

20.16

nmol/l

1.16

316

3711

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

3.25

5.45

3.5

1.07

1.82

ug/l

0.78

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

199

2.19

5.40

1.7

1.3

—

(4062490) Immunoglobulin typing, IgG

142

2.42

5.39

1.4

1.5

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1196

0.56

5.36

1.4

1.5

—

(3042631) Mycobacterium sp identified in Specimen

149

2.37

5.33

1.6

3.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

486

5816

0.78

5.25

4.1

3.9

2.37

1.85

ug/l

1.66

436

5282

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

208

2.14

5.25

1.5

2.0

—

1760.00

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

567

1.67

5.11

2.2

1.4

19.32

22.80

iu/l

0.56

479

(3027135) IgG subclass 1 [Mass/volume] in Serum

146

2.35

5.09

1.4

6.01

6.90

g/l

0.78

112

(3028192) IgG subclass 2 [Mass/volume] in Serum

146

2.35

5.09

1.4

2.59

2.91

g/l

0.49

110

(3024139) IgG subclass 3 [Mass/volume] in Serum

146

2.35

5.09

1.4

0.34

0.35

g/l

0.07

111

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.68

5.08

2.3

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

177

1251

1.46

5.07

3.0

2.2

70.81

69.51

e9/l

0.20

132

910

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

433

0.32

4.86

1.2

1.3

—

(3016038) Potassium [Moles/volume] in Urine

107

2.55

4.80

1.2

1.3

30.28

34.89

mmol/l

0.76

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

6.50

4.77

1.2

1.4

—

(3028433) Virus identified in Specimen by Culture

3.59

4.77

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

388

4725

0.77

4.73

2.9

3.3

923.20

1352.31

ng/l

2.53

341

4034

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

187

1357

1.42

4.66

2.1

2.4

33.27

75.80

u/l

0.63

155

1143

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

7.18

4.65

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

6.70

4.47

1.1

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

4.40

4.43

1.1

1.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

546

1.62

4.32

2.2

1.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

5.03

4.32

1.8

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

705

0.50

4.23

1.3

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.81

4.12

2.0

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

209

1.98

4.08

1.1

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

272

3407

0.76

4.05

2.7

2.8

0.72

0.71

ug/l

0.09

178

2061

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

124

857

1.48

4.03

3.2

2.9

1.18

1.24

0.37

124

852

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

176

2.07

4.01

2.0

1.5

0.23

0.33

nmol/l

1.04

147

(3005322) IgE [Units/volume] in Serum or Plasma

1103

0.61

3.97

1.4

1.3

321.58

261.65

u/ml

0.20

1030

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

133

935

1.45

3.96

3.6

4.8

1.81

1.67

mmol/l

0.23

111

674

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

597

0.48

3.96

1.5

1.8

3.56

5.09

mg/l

0.57

428

(3024869) Neuronal Ab [Presence] in Serum

4.47

3.93

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

7.30

3.86

1.5

4.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.61

3.81

2.0

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.96

3.79

1.5

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1052

11361

0.83

3.76

3.9

4.3

11.50

10.98

mm/h

0.57

984

10650

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.66

3.73

2.1

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

245

1.86

3.72

1.8

1.4

—

(40768800) Prostate Pathology biopsy report

2.58

3.72

1.3

1.1

—

(3000492) Spirometry study

111

1580

0.68

3.71

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

500

0.45

3.67

1.3

1.6

1478.74

992.77

mu/l

1.15

414

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

103

2.35

3.67

2.0

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

103

2.35

3.67

2.0

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

103

2.35

3.67

2.0

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.13

3.65

1.2

1.1

88.50

90.46

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

255

1.82

3.60

1.7

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.06

3.53

1.2

1.0

92.88

88.83

—

(40761536) Microorganisms panel - Urine sediment

150

1103

1.39

3.51

4.2

3.7

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

10.03

3.50

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

476

0.46

3.49

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

268

3297

0.78

3.43

1.5

1.7

51339777.32

45677189.26

pmol/l

0.04

224

2741

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.77

3.39

2.2

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.77

3.39

2.2

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.77

3.39

2.2

1.2

—

(3003129) Base excess in Capillary blood by calculation

194

0.26

3.37

1.6

2.3

-0.24

0.31

mmol/l

—

189

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

8.59

3.26

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

8.59

3.26

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

771

0.59

3.25

1.4

1.6

0.44

0.33

mg/l

0.40

384

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

123

2.13

3.20

2.0

1.2

2.72

3.09

ug/l

0.21

112

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

451

1.57

3.20

1.6

1.5

49.43

24.94

u/ml

0.88

427

(3024980) IgG subclass 4 [Mass/volume] in Serum

251

1.77

3.18

1.5

1.7

0.58

0.91

g/l

1.70

206

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

156

2040

0.74

3.15

1.6

1.8

1.82

1.47

2.53

129

1813

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

4.52

3.11

1.1

1.9

—

(4024509) Urine culture

686

0.57

3.09

1.6

1.9

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

10.02

2.98

1.2

1.90

1.40

mg/l

—

(40768793) Breast Pathology biopsy report

2.25

2.96

1.3

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.71

2.89

2.1

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.71

2.89

2.1

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.71

2.89

2.1

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.71

2.89

2.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.46

2.79

1.0

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

128

1691

0.74

2.78

1.7

2.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.93

2.77

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

725

0.61

2.76

1.4

2.2

—

(3022475) Manganese [Moles/volume] in Blood

8.35

2.75

1.4

1.0

0.14

umol/l

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1113

10425

1.17

2.71

4.1

3.3

67.07

45.93

u/l

4.70

1068

9799

(3037522) Nuclear Ab [Titer] in Serum

174

2188

0.77

2.65

1.3

673.33

548.76

titre

0.27

477

(3000475) Leukocytes [#/volume] in Synovial fluid

402

0.49

2.65

1.4

1.5

5557.91

12696.57

e6/l

1.59

290

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1567

15119

1.22

2.64

28.6

13.7

21.42

23.58

mg/l

2.47

1475

12139

(3014271) Vancomycin [Susceptibility]

2.40

2.63

2.6

—

(3036603) Volume of Urine

2.26

2.61

1.7

1.6

1896.94

1943.12

0.10

(3023420) DNA double strand Ab [Units/volume] in Serum

676

0.61

2.58

1.5

1.9

9.10

6.77

iu/ml

—

154

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.61

2.57

1.2

1.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

771

0.64

2.55

1.0

1.1

—

1.79

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

180

0.33

2.54

1.3

1.5

53.16

53.38

ug/l

—

180

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

108

798

1.37

2.53

3.8

3.7

53.13

48.36

1.30

108

780

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

472

1.48

2.47

14.2

4.6

1.13

1.53

mg/l

5.37

427

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.68

2.45

1.3

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

119

1553

0.75

2.41

1.6

2.1

—

(3044941) Cell count panel - Synovial fluid

294

0.44

2.40

1.2

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.34

2.39

1.2

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

864

0.67

2.37

1.5

2.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

6.26

2.37

1.0

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.13

2.36

1.0

1.3

—

(3009343) pH of Capillary blood

137

1064

1.31

2.33

3.7

4.9

7.42

7.41

1.89

126

874

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

157

0.32

2.26

1.2

1.4

97.46

222.76

pmol/l

—

157

(3013139) Helicobacter pylori Ag [Presence] in Stool

1052

0.71

2.26

1.2

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.90

2.25

1.4

2.1

3.14

5.22

ug/l

—

(3021788) Differential panel - Synovial fluid

298

0.47

2.23

1.2

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

363

0.52

2.21

1.4

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

345

3960

0.84

2.20

2.0

2.3

2.71

mg/l

0.01

298

3397

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

212

0.42

2.19

2.3

1.7

—

(3019150) Specific gravity of Urine by Refractometry

321

3704

0.84

2.18

3.9

1.02

1.44

kg/l

0.50

222

2388

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

230

2737

0.82

2.17

1.4

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

557

6149

0.87

2.15

4.0

3.6

0.03

0.09

estimate

0.34

154

1291

(3048929) Epstein Barr virus Ab [Presence] in Serum

514

1.42

2.10

1.2

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

3.21

2.09

1.5

2.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

382

1.48

2.07

2.3

1.4

3.02

1.39

ratio

0.94

214

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

5.01

2.07

1.2

1.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1590

16311

0.84

2.07

34.9

17.5

72.23

78.76

umol/l

18.33

1576

16103

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

0.00

2.07

0.0

3.2

—

72.79

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

441

1.44

2.05

1.1

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

655

1.36

2.02

1.7

2.0

32.74

39.21

u/l

2.48

581

(3016244) Insulin [Units/volume] in Serum or Plasma

1.97

2.00

3.4

3.5

13.89

25.90

mu/l

1.08

(21494890) Protein electrophoresis panel - 24 hour Urine

119

1.86

1.97

1.8

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

4.55

1.94

1.2

1.0

—

(40768797) Stomach Pathology biopsy report

170

2062

0.81

1.94

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

158

1.72

1.89

3.1

2.4

1.18

1.19

mmol/l

0.28

158

(3022145) Colonoscopy Study observation

122

1532

0.78

1.89

1.2

1.3

—

(3011648) Oxygen content in Venous blood

189

1.65

1.88

5.1

2.1

12.39

10.92

0.82

189

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

381

0.57

1.87

1.3

1.2

—

4.91

—

(3024928) Oxygen saturation in Venous blood

419

1.42

1.81

4.0

3.0

64.31

62.23

0.29

407

(4146454) Self-monitoring of blood glucose

183

0.43

1.81

2.3

2.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.05

1.80

1.0

—

(40757373) Influenza virus identified in Isolate

2.77

1.79

1.5

1.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

116

1.82

1.78

1.9

2.5

35.23

34.14

mg/l

0.04

(3000012) Reticulocyte production index

169

1.67

1.77

2.3

1.8

1.09

0.92

0.68

111

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1575

16134

0.85

1.77

21.3

10.1

32.95

26.99

u/l

13.82

1555

15631

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

322

1.47

1.75

1.3

1.4

242.85

243.40

u/ml

0.00

192

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.92

1.72

1.4

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.92

1.72

1.4

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.92

1.72

1.4

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.92

1.72

1.9

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

163

1.67

1.71

3.1

2.4

105.11

105.50

mmol/l

0.14

163

(3041354) Potassium [Moles/volume] in Venous blood

163

1.67

1.71

3.1

2.4

4.08

4.06

mmol/l

0.09

163

(3008898) HLA-B27 [Presence]

562

0.67

1.68

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

0.00

1.68

0.0

1.2

—

37.33

—

(3047189) Immunofixation for 24 hour Urine

2.45

1.64

1.2

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

120

1.76

1.62

1.0

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

121

975

1.26

1.61

2.5

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

3.58

1.61

1.2

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

396

0.63

1.54

2.4

2.3

448.83

124.18

ug/min

0.45

250

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

142

0.42

1.52

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.87

1.50

1.1

1288.56

1706.35

miu/ml

0.66

(3020630) Protein [Mass/volume] in Serum or Plasma

142

1177

1.22

1.49

4.0

1.5

65.02

67.07

g/l

1.99

126

1075

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

101

1.79

1.49

1.2

1.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.44

1.48

1.2

2.4

23.81

19.16

umol/l

—

(3020876) Protein [Mass/time] in 24 hour Urine

147

1.64

1.47

1.6

1.8

1.58

1.93

g/24h

0.20

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

3.13

1.44

2.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

794

0.75

1.43

1.0

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

432

1.35

1.40

1.2

1.3

59.09

101.70

titre

1.71

(3041096) Erythrocytes [Presence] in Urine by Automated

394

4338

0.88

1.40

3.6

3.1

0.00

0.21

estimate

0.52

144

1241

(3000093) Morphology [Interpretation] in Blood Narrative

126

1.67

1.40

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.18

1.40

1.0

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

143

1195

1.21

1.40

3.6

2.3

67.84

67.15

ml/min/173m2

0.06

499

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

421

0.66

1.39

1.3

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.01

1.38

1.3

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

236

0.55

1.37

1.2

1.6

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

124

0.40

1.36

35.4

21.9

1135.60

1437.52

nmol/l

—

118

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

436

1.34

2.8

1.4

25.88

33.68

mg/l

0.96

365

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1270

13121

0.90

1.33

36.1

17.7

334.89

333.27

g/l

8.27

1261

13051

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.97

1.33

2.4

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.97

1.33

2.4

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

246

0.57

1.33

1.2

1.6

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

1.32

0.0

1.1

—

56.13

—

(4195642) Thrombophilia screening test

217

1.48

1.31

1.1

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

438

1.33

1.30

2.8

1.4

38.48

42.37

mg/l

0.31

368

(3014051) Protein [Presence] in Urine by Test strip

397

4349

0.89

1.29

2.9

0.00

0.02

0.50

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

251

1.44

1.29

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.89

1.28

2.2

2.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

114

1.67

1.28

1.2

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

135

0.44

1.27

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

135

0.44

1.27

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

135

0.44

1.27

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

135

0.44

1.27

1.2

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

204

0.54

1.26

1.2

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

159

1854

0.84

1.26

3.7

5.0

30.97

32.16

0.77

120

1236

(3047352) Trisomy 18 risk [Likelihood] in Fetus

229

0.56

1.25

1.2

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

278

0.61

1.24

1.2

1.5

0.89

0.94

ratio

—

171

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

278

0.61

1.24

1.2

1.5

1.63

1.20

ratio

—

171

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

278

0.61

1.24

1.2

1.5

1.86

1.14

ratio

—

171

(3032773) Endomysium IgG Ab [Titer] in Serum

160

0.50

1.24

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

160

0.50

1.24

1.3

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

119

0.42

1.24

19.6

17.5

589.80

797.85

nmol/l

—

114

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

159

1850

0.85

1.23

1.3

1.5

—

(3045414) Leukocytes [Presence] in Urine

117

1399

0.83

1.23

2.1

2.0

0.00

0.02

estimate

0.78

286

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

277

0.61

1.23

1.2

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

237

1.44

1.23

1.1

1.2

4.85

6.05

u/ml

0.19

114

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.91

1.22

1.3

1.6

—

1493314.14

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

1.91

1.22

1.0

1.1

—

5.17

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

141

0.49

1.20

1.0

1.5

22.00

26.05

—

(3032057) Clostridioides difficile [Presence] in Stool

2.31

1.18

2.5

2.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

341

1.36

1.18

4.2

4.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

126

0.47

1.16

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

333

0.66

1.16

1.1

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

129

0.46

1.16

1.2

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

198

0.55

1.16

1.4

1.3

—

64.84

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

1.16

0.0

1.0

—

46.93

—

(1002224) Polysomnography panel

822

0.78

1.15

1.1

—

(4198724) Urine methamphetamine measurement

1.81

1.15

1.3

1.9

—

(3038515) Glucose [Moles/volume] in Venous blood

309

1.37

1.14

3.8

2.9

7.20

7.36

mmol/l

0.17

297

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

361

1.34

1.14

1.1

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

136

0.51

1.09

1.3

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.82

1.09

1.0

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

567

0.75

1.06

1.7

1.6

22.24

15.64

u/ml

—

132

(3047007) Chlamydophila sp Ab [Presence] in Serum

229

0.61

1.05

1.0

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

121

0.49

1.05

1.2

1.1

—

(3025130) Human papilloma virus identified in Specimen

191

0.57

1.04

1.6

1.8

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1418

14506

0.91

1.03

27.3

12.9

88.65

81.35

ml/min/173m2

37.33

1312

13297

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

273

1.36

1.01

1.4

1.7

—

(36660697) Celiac disease serology panel - Serum

107

1261

0.84

1.00

1.1

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1583

15545

1.12

0.99

31.6

16.7

139.05

139.77

mmol/l

18.87

1569

15228

(3008037) Lactate [Moles/volume] in Venous blood

370

1.31

0.99

4.2

2.8

1.58

1.59

mmol/l

0.02

356

(40762814) Titanium [Mass/volume] in Blood

0.00

0.97

0.0

2.7

—

3.06

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1125

0.84

0.94

3.3

4.2

88.66

91.54

ng/l

0.09

984

(3004716) Salmonella sp identified in Stool by Organism specific culture

722

0.80

0.94

1.2

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.90

0.94

1.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.72

0.92

1.0

1.2

—

14.56

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

126

1.51

0.91

1.4

1.2

114.05

107.65

pmol/l

0.18

126

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

502

1.24

0.89

1.2

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

194

0.62

0.89

1.3

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

254

1.34

0.88

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1305

12725

1.08

0.88

36.0

16.6

13.87

13.50

20.80

1298

12526

(40768806) Pleura Pathology biopsy report

1.61

0.87

1.6

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

522

1.23

0.87

2.2

1.7

431.93

293.43

mu/l

1.24

475

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

229

1.36

0.87

1.1

—

(3027944) Amphetamines [Presence] in Urine

637

0.80

0.87

3.1

2.2

—

(3022313) Gas panel - Capillary blood

780

1.19

0.85

4.3

5.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

154

1.43

0.83

1.6

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.74

0.82

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

686

0.81

1.8

2.0

41.88

39.56

nmol/l

0.30

663

(3025468) Yersinia sp identified in Specimen by Organism specific culture

155

1.42

0.81

1.6

1.2

—

(4268621) Lupus anticoagulant assay

172

1.40

0.81

2.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

156

1.42

0.79

1.6

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

216

1.35

0.79

1.1

1.49

1.48

g/l

0.12

196

(3000764) Benzodiazepines [Presence] in Urine

639

0.81

0.78

3.0

2.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

985

0.85

0.78

1.2

173.03

132.56

u/ml

0.23

400

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

269

0.70

0.78

1.1

1.4

—

10.44

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

222

0.67

0.77

1.0

1.1

—

2.23

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

107

1.50

0.76

1.3

41284.29

97942.74

e6/l

—

(3037756) Immunofixation for Serum or Plasma

227

1.33

0.74

1.9

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

2.09

0.74

1.2

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

245

1.31

0.74

1.1

1.2

5.62

3.62

u/ml

0.25

(3023103) Potassium [Moles/volume] in Serum or Plasma

1582

15589

1.09

0.73

31.3

16.8

3.95

3.98

mmol/l

6.39

1566

15238

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.00

0.72

1.2

113.60

92.60

—

(3016879) Cocaine [Presence] in Urine

599

0.81

0.72

3.2

2.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

426

1.23

0.71

1.8

1.3

0.10

0.00

g/l

0.62

395

(3002619) Bacteria identified in Specimen by Culture

1.93

0.70

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.93

0.70

1.4

3.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

286

0.73

0.70

1.1

—

19.93

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

202

1841

1.11

0.70

9.9

6.3

—

(3045424) Erythrocytes [Presence] in Urine

716

0.83

0.70

2.0

0.05

1.14

estimate

0.48

223

(3000330) Specific gravity of Urine by Test strip

741

1.17

0.69

3.9

3.4

1.02

ratio

2.04

681

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

195

1.34

0.69

1.4

1.3

—

nmol/l

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

1.60

0.68

1.3

1.1

104.91

82.53

u/l

0.21

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

412

1.22

0.66

1.8

1.3

0.00

g/l

-0.00

374

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

157

1417

1.12

0.66

2.0

2.4

3.78

8.27

ug/l

9.98

134

1264

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

431

1.21

0.65

1.2

1.1

—

3.85

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

1.57

0.65

1.3

1.1

25.18

21.78

u/l

0.07

(3028300) Cannabinoids [Presence] in Urine

645

0.83

0.65

3.1

2.2

—

(3027008) Opiates [Presence] in Urine

643

0.84

0.63

3.0

2.3

—

(40768443) Skin Pathology biopsy report

567

0.82

0.63

1.2

—

(3044927) Protein electrophoresis panel - Urine

165

0.66

0.63

1.2

1.1

—

(4034850) Laboratory test

545

0.82

0.63

10.4

9.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

637

1.17

0.62

1.8

1.7

1.57

1.52

g/l

0.17

556

(3015736) pH of Urine

626

6515

0.94

0.60

3.4

3.3

6.35

6.23

1.72

340

3647

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

165

1.34

0.60

1.6

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

140

0.64

0.60

1.3

1.1

—

38.60

—

(3048879) Bone marrow aspiration report

0.00

0.60

0.0

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

509

0.82

0.59

3.5

2.3

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.00

0.59

0.0

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

166

1.33

0.58

1.6

1.2

—

(3000494) Fungus identified in Specimen by Culture

201

1853

1.09

0.58

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.72

0.57

1.0

1.3

—

0.40

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

365

1.21

0.56

1.7

2.2

137.19

132.76

g/l

0.58

302

(3019832) Treponema pallidum Ab [Presence] in Serum

152

1384

1.11

0.56

1.3

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.57

0.56

1.0

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

384

1.20

0.56

1.4

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

213

1.27

0.54

1.2

1.3

—

(4211845) Urine protein measurement

1.52

0.52

2.7

3.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

146

0.68

0.52

1.1

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

402

0.82

0.51

1.7

2.1

3.82

17.37

iu/l

0.50

172

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

224

1.25

0.51

1.3

0.64

8.57

nmol/l

0.50

215

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.46

0.50

3.0

9.80

9.97

kpa

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.46

0.50

3.0

4.44

5.09

kpa

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

179

0.72

0.50

1.2

1.3

—

(44806420) Estimation of glomerular filtration rate

155

0.71

0.48

2.2

2.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

391

1.18

0.48

1.7

1.4

0.00

g/l

-0.00

373

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.46

0.46

1.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

176

0.74

0.46

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

118

0.68

0.45

1.3

1.1

—

63.27

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

351

3347

1.06

0.44

2.0

1.8

2.11

1.24

mg/l

2.06

294

2540

(3024522) Salmonella sp identified in Specimen by Organism specific culture

166

1.27

0.43

1.6

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

245

2593

0.94

0.42

1.7

1065.45

1168.28

nmol/l

1.23

191

1985

(3044242) Glucose [Moles/volume] in Arterial blood

0.65

0.42

1.2

1.8

7.80

8.51

mmol/l

—

(3011288) Drugs identified in Urine by Screen method Nominal

434

0.85

0.41

2.4

3.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

501

1.14

0.41

1.7

1.4

0.98

0.35

g/l

0.71

437

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.9

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

29.20

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.41

0.0

1.3

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

37.50

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

6.48

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

380

0.84

0.41

1.4

1.5

—

(3009015) Lactate [Moles/volume] in Synovial fluid

0.00

0.40

0.0

1.2

—

6.23

—

(3019174) dRVVT (LA screen)

0.00

0.40

0.0

1.2

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.40

0.0

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.33

0.40

1.1

1.2

—

(3006462) Nitrate [Presence] in Urine

1.33

0.40

3.1

3.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

159

1.26

0.40

1.8

2.4

19.00

20.68

mg/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.37

0.40

1.8

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.34

0.39

1.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

783

8020

0.96

0.39

3.8

3.7

0.01

0.00

estimate

0.50

186

1571

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.39

0.38

2.0

2.8

0.62

0.61

mmol/l

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.31

0.37

1.3

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.39

0.37

1.9

1.4

5.16

4.96

umol/l

—

(3018133) Calcium [Moles/volume] in Urine

1.40

0.35

1.3

2.4

2.97

2.68

mmol/l

—

(3035350) Ketones [Presence] in Urine by Test strip

796

8135

0.96

0.35

3.8

3.7

6.87

4.12

estimate

0.15

193

1596

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.33

0.33

1.2

1.8

339.50

70.09

nmol/24h

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

465

0.88

0.32

1.3

127.42

232.70

miu/ml

1.01

205

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

137

1.24

0.32

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

128

1.25

0.32

1.3

960.09

2219.47

e6/l

1.71

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

551

1.11

0.31

1.6

1.4

2.91

2.88

g/l

0.07

493

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

401

1.13

0.29

2.6

2.1

6.95

5175.46

u/l

3.59

176

(3011397) Hemoglobin [Presence] in Urine by Test strip

386

3736

1.04

0.29

3.6

0.00

0.03

—

(3022621) pH of Urine by Test strip

112

1196

0.93

0.28

2.6

2.7

6.28

6.08

1.44

814

(3026493) Urate [Moles/volume] in Serum or Plasma

391

4034

0.96

0.28

3.0

2.5

310.28

352.26

umol/l

12.67

351

3539

(3007164) IgA [Mass/volume] in Serum or Plasma

296

3072

0.96

0.28

2.1

1.4

2.25

2.52

g/l

0.82

197

1884

(3006270) Folate [Moles/volume] in Blood

119

0.76

0.27

1.2

298.89

385.00

nmol/l

—

108

(3017704) Immunofixation for Urine

0.67

0.26

1.8

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.67

0.25

1.4

2.5

182.60

150.42

nmol/l

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

588

1.09

0.25

1.8

1.4

7.41

7.39

g/l

0.04

530

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

588

1.09

0.25

1.8

1.4

4.18

4.25

g/l

0.23

530

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

521

1.10

0.25

1.8

1.4

10.31

10.27

g/l

0.02

461

(3009261) Glucose [Presence] in Urine by Test strip

803

8166

0.97

0.25

3.9

3.7

0.02

estimate

0.10

184

1477

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.22

0.25

1.6

2.0

1.24

6.89

nmol/l

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.20

0.25

1.1

1.6

4.09

10.32

ug/l

—

(3029937) Albumin [Presence] in Urine by Test strip

432

4431

0.97

0.23

4.2

3.8

0.00

estimate

0.88

167

1458

(3010838) Calcium [Moles/time] in 24 hour Urine

247

1.14

0.22

1.5

2.2

5.13

5.38

mmol/24h

0.11

216

(4133840) Spirometry

1.25

0.22

1.0

1.2

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

1.25

0.22

1.6

1.4

40.24

54.51

—

(3002523) Influenza virus A Ag [Presence] in Specimen

294

0.88

0.21

1.2

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

1.19

0.21

1.4

2.7

16577.60

431.21

e6/l

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.21

0.0

1.8

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.21

0.0

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.21

0.0

1.0

—

0.05

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.21

0.0

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

71.17

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.3

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

12.25

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.16

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

105

0.76

0.21

1.0

1.4

—

346.00

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.16

0.21

6.0

7.7

6.52

5.08

kpa

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

293

0.89

0.21

1.2

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

132

1259

1.05

0.20

2.0

3.4

165.77

209.56

ng/l

0.62

118

1158

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.20

0.0

1.4

—

5.97

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.00

0.20

0.0

10.6

—

0.21

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.25

0.20

1.5

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.25

0.20

1.5

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

240

1.13

0.20

1.8

2.4

—

10.00

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

588

1.07

0.19

1.8

1.4

3.76

3.72

g/l

0.08

530

(3012441) Differential panel - Pleural fluid

109

1.19

0.18

1.4

1.3

—

(3017732) Neutrophils [#/volume] in Blood

189

1826

1.04

0.18

3.9

2.9

4.25

4.92

e9/l

0.65

173

1572

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

176

1.14

0.17

1.1

102.60

97.29

0.44

167

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

219

2124

1.04

0.17

2.0

2.7

26.08

23.43

1.43

204

1981

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

731

0.94

0.16

2.2

2.4

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

1.11

0.16

1.5

1.7

27.63

27.23

umol/l

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

285

1.09

0.14

1.1

1.00

122.04

iu/ml

—

(3022948) Iron [Moles/volume] in Serum or Plasma

246

2515

0.97

0.13

2.0

2.6

14.54

13.45

umol/l

1.30

230

2333

(42529406) Shigella sp [Presence] in Stool by Culture

427

0.94

0.12

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

171

1.11

0.12

1.3

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

416

0.94

0.12

1.4

299.48

304.91

ug/g

0.07

249

(3028707) Methadone [Presence] in Urine by Screen method

278

1.08

0.12

4.4

3.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

454

1.06

0.11

1.1

1.3

—

7.11

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

150

1540

0.97

0.11

2.6

2.4

12.63

14.60

nmol/l

2.21

133

1417

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.16

0.11

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

319

1.07

0.10

2.6

3.5

22.44

26.89

mg/l

0.29

224

(3014765) Yersinia sp identified in Stool by Organism specific culture

422

0.95

0.09

1.2

1.1

—

(3025941) Bacteria identified in Stool by Culture

766

0.96

0.09

1.2

—

(3012565) Volume of 24 hour Urine

1.05

0.08

2.2

2.0

2325.00

2078.02

—

(3003327) Ova and parasites identified in Stool by Light microscopy

532

0.96

0.08

2.0

1.8

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

113

0.88

0.08

1.1

1.6

79.10

85.04

umol/l

—

113

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.82

0.08

1.2

1.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.83

0.08

1.4

1.1

—

4.31

—

(40768446) Kidney Pathology biopsy report

0.79

0.08

1.0

1.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

185

1.08

0.08

1.5

1.3

—

(3020491) Glucose [Moles/volume] in Blood

117

1.11

0.08

1.8

2.2

6.74

6.78

mmol/l

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

127

1.10

0.08

2.0

2.4

1.86

2.00

u/field

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.03

0.07

1.4

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

254

1.06

0.07

1.3

1.1

—

1.14

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.08

0.07

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

418

0.96

0.07

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

112

0.89

0.07

1.4

1.2

—

(3017569) Oxygen content in Arterial blood

1.02

0.07

1.3

1.9

16.51

16.96

—

(3045788) Cell count panel - Pleural fluid

109

1.10

0.06

1.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

236

2333

1.01

0.05

1.9

2.6

2.28

2.32

g/l

0.46

220

2152

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

110

1.09

0.05

1.3

1.1

—

(3049717) Cytology report of Urine Cyto stain

434

0.97

0.05

3.0

1.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

466

1.03

0.04

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

476

4736

1.01

0.03

2.8

2.4

56.02

60.23

u/l

0.90

449

4381

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

260

1.04

0.03

1.4

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

142

1.06

0.02

1.1

309.20

283.20

mg/l

0.50

132

(44813793) Dust mix specific IgE antibody measurement

103

1.07

0.02

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

247

0.97

0.01

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

597

0.99

0.01

1.3

1.2

—

(3004775) Volume in Urine collected for unspecified duration

114

1.05

0.00

2.1

2.4

733.71

627.37

—

(3006653) Thiamine [Moles/volume] in Blood

1.05

0.00

1.0

1.3

123.80

142.26

nmol/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

104

0.96

0.00

1.4

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

208

1.01

0.00

1.0

1.1

0.87

2.79

eliau/ml

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

113

0.97

0.00

1.4

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

157

1.02

0.00

2.4

4.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

2.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

7.87

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

0.00

0.0

1.4

—

839.75

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3022689) Creatine [Moles/volume] in Urine

0.88

-0.00

1.4

6.80

10.05

mmol/l

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

5.3

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.96

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.7

—

1.36

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(4212803) Bone marrow aspirate examination

0.00

-0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

34.36

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.99

-0.00

1.0

1.2

7.43

8.06

mm/h

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.1

—

3.24

—

(3023419) Bacteria identified in Sputum by Culture

200

1.00

-0.00

1.8

3.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.02

-0.00

1.2

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.4

—

410.60

—

(4281824) Cell count and differential, peritoneal fluid

0.92

-0.00

1.2

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

3.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

2.8

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3004451) EKG impression Narrative

1.01

-0.00

1.2

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

-0.00

0.0

3.2

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

3.00

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_EYE_BRAIN_NEURO – Malignant neoplasm of eye, brain and central nervous system

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of eye, brain and central nervous system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints